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ABSTRACT 
Stringer, Megan Elizabeth. M.S., Purdue University, December 2015. Effect of 
Epigallocatechin-3-Gallate on a Pattern Separation Task and Hippocampal Neurogenesis 
in a Mouse Model of Down Syndrome. Major Professor: Charles Goodlett. 
 
 
Down syndrome (DS) is caused by three copies of human chromosome 21 
(Hsa21) and results in an array of phenotypes including intellectual disability. Ts65Dn 
mice, the most extensively studied DS model, have three copies of ~50% of the genes on 
Hsa21 and display many phenotypes associated with DS, including cognitive deficits.  
DYRK1A is found in three copies in humans with Trisomy 21 and in Ts65Dn mice, and is 
involved in a number of critical pathways including CNS development and 
osteoclastogenesis.  Epigallocatechin-3-gallate (EGCG), the main polyphenol in green 
tea, inhibits Dyrk1a activity. We have shown that a three-week EGCG treatment 
(~10mg/kg/day) during adolescence normalizes skeletal abnormalities in Ts65Dn mice, 
yet the same dose did not rescue deficits in the Morris water maze spatial learning task 
(MWM) or novel object recognition (NOR).  Others have reported that An EGCG dose of 
2-3 mg per day (90mg/ml) improved hippocampal-dependent task deficits in Ts65Dn 
mice.  The current study investigated deficits in a radial arm maze pattern separation task 
in Ts65Dn mice.  Pattern separation requires differentiation between similar memories 
acquired during learning episodes; distinguishing between these similar memories is 
thought to depend on distinctive encoding in the hippocampus.  Pattern separation has 
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been linked to functional activity of newly generated granule cells in the dentate gyrus.  
Recent studies in Ts65Dn mice have reported significant reductions in adult hippocampal 
neurogenesis, and after EGCG treatment, enhanced hippocampal neurogenesis.  Thus, it 
was hypothesized that Ts65Dn mice would be impaired in the pattern separation task, and 
that EGCG would alleviate the pattern separation deficits seen in trisomic mice, in 
association with increased adult hippocampal neurogenesis.  At weaning, Ts65Dn mice 
and euploid littermates were randomly assigned to the water control, or EGCG [0.4 
mg/mL], with both treatments yielding average daily intakes of ~50 mg/kg/day.  
Beginning on postnatal day 75, all mice were trained on a radial arm maze-delayed non-
matching-to-place pattern separation task.  Euploid mice performed significantly better 
over training than Ts65Dn mice, including better performance at each of the three 
separations.  EGCG did not significantly alleviate the pattern separation deficits in 
Ts65Dn mice.  After the behavioral testing commenced, animals were given ad libitum 
food access for five days, received a 100mg/kg injection of BrdU, and were perfused two 
hours later.  Coronal sections through the dorsal hippocampus were processed for BrdU 
labeling, and cells were manually counted throughout the subgranular zone of the dentate 
gyrus.  The euploid controls had significantly more BrdU labeled cells than Ts65Dn 
mice, however, EGCG does not appear to increase proliferation of the hippocampal 
neuroprogenitor cells.  This is the first report of deficits in Ts65Dn mice on a pattern 
separation task. To the extent that pattern separation depends on the functional 
involvement of newly generated neurons in an adult dentate gyrus, this approach in 
Ts65Dn mice may help identify more targeted pharmacotherapies for cognitive deficits in 
individuals with DS. 
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CHAPTER 1. INTRODUCTION 
1.1 Down syndrome 
Down syndrome (DS) occurs in approximately 1 in every 700 live births and 
results from the triplication of  human chromosome 21 (Hsa21) (Parker et al., 2010).  The 
genetic basis of DS was discovered in 1958 by John Lejeune who observed an extra copy 
of human chromosome 21 in human tissue samples (Lejeune, Gautier, & Turpin, 1959).  
The most common cause of DS is a non-disjunction of Hsa21 during meiosis, where 
Hsa21 does not completely separate, or a Robertsonian translocation (three copies of long 
arm Hsa21) (Epstein, 2001).  The only known risk factor of DS is advanced maternal age 
(Yoon et al., 1996).   
One of the first observations of individuals with DS was from John Down in 
London in 1866.  He noted that all of these individuals resembled individuals from 
Mongolia, so he deemed the patients “Mongols.”  He described a group of patients as 
having a flat, broad face, long tongue, and a small nose.  He described their speech as 
“thick and indistinct”, and their personalities as “humorous.”  According to Down, the 
patients improved their speech with training, but their life expectancy was well below the 
average.  In 1961, the journal The Lancet published a letter from nineteen researchers, 
stating that the term “mongol” should no longer be used.  The researchers stated that 
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“mongol” was an “embarrassing term”, and that the resemblance of these individuals to 
the Mongolian people was “superficial” and should no longer be used.  In 1965, the 
World Health Organization removed the term “mongolism” and instead “Down’s 
syndrome” was used (Howard-Jones, 1979).  In 1975, the National Institute of Health 
stated that “Down’s syndrome” should be replaced with “Down syndrome”.   
 
1.1.1 Phenotypes of DS 
DS results in an array of phenotypes that affect the cardiovascular, skeletal and 
central nervous systems.  Heart defects affect 40-50% of children with DS (Freeman et 
al., 2008; Freeman et al., 1998; Tubman et al., 1991).  Bone deficits, including a 
reduction in bone mineral density, and an increased incidence of osteoporosis have also 
been reported (Center, Beange, & McElduff, 1998; Guijarro et al., 2008).  A lower 
intelligence quotient (IQ) is one of the most common phenotypes, along with hearing loss 
(75%), obstructive sleep apnea (50%-80%), eye disease (60%), and an Alzheimer-like 
phenotype in individuals that live over 35-40 years, with plaques accumulating in 
individuals as young as eight years old (Bull, 2011; Källén, Mastroiacovo, & Robert, 
1996; Leverenz & Raskind, 1998; Marcus et al., 1991; Netzer et al., 2010; Shott, Joseph, 
& Heithaus, 2001; Zigman & Lott, 2007).  It is important to note that while these 
phenotypes are common among individuals with DS, there is a wide range of variability 
in the incidence and severity of the various phenotypes (Roubertoux & Kerdelhué, 2006). 
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1.1.2 Structural and histological deficits observed in DS 
Individuals with DS show differences in brain development from typically-
developing individuals that emerge early in life.  A handful of studies have examined 
fetuses with DS to determine if histological differences are present during prenatal 
development.  One study found that at 15-22 weeks, there were no differences in the 
cerebellum or brain stem size, nor were there differences in the size of the hippocampus.  
However, this study employed qualitative-based analysis (Schmidt-Sidor et al., 1990).  
More recent studies have employed advanced methods, such as morphometry, stereology 
and cell phenotyping based techniques.  For example, in 17-21 week postmortem fetuses, 
a reduction in the volume and number of cells in the hippocampus, dentate gyrus (DG) 
and parahippocampal gyrus was observed.  Fetuses with DS also displayed higher levels 
of cells displaying an astrocyte phenotype versus a neuronal phenotype, possibly due to 
the observed reduction in hippocampal proliferation (Guidi et al., 2008). Another study 
found similar results, with 17-21 week fetuses having a smaller proportion of neurons 
versus astrocytes, together with deficits in cell proliferation (Contestabile et al., 2007).  
These histological deficits extend into postnatal development, with 3-5 months 
old infants with DS displaying a smaller brain stem and cerebellum, as well as a lower 
brain weight.  These infants also display deficits in myelination within the brain stem, 
cerebellum, spinal cord and posterior horn (Wisniewski, 1989).  Abnormal dendritic 
branching and shorter dendritic length, as well as prefrontal, visual and motor cortex 
neuron abnormalities have also been observed in individuals with DS (Becker, 
Armstrong, & Chan, 1986; Marin-Padilla, 1976; Takashima et al., 1981; Takashima et 
al., 1994; Vukšić et al., 2002).  Decreases in visual cortex myelination have also been 
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noted (Wisniewski, 1989).  Structurally, children with DS show significantly smaller 
hippocampal and cerebellar volumes (Jernigan et al., 1993; Pinter et al., 2001a; Pinter et 
al., 2001b).   Continuing into adulthood, adults with DS display a range of deficits, 
including a smaller corpus callosum, and decreases in hippocampal, cerebellar, cerebral 
cortex and white matter volumes versus age matched controls (Aylward et al., 1997; 
Aylward et al., 1999; Kesslak et al., 1994; Weis et al.).  Individuals with DS have been 
shown to develop plaques and neurofibrillary tangles, typical of Alzheimer’s disease, 
before the age of 40.  These histological changes occur in multiple areas of the brain, 
including the entorhinal cortex and the DG of the hippocampal formation (Motte & 
Williams, 1989). 
 
1.1.3 Behavioral deficits observed in DS 
DS is the most common genetic cause of an intellectual disability (Yamakawa, 
2012).  All individuals with DS have an intellectual disability, with an average IQ of 50 
and ranging from 30-70 (Chapman & Hesketh, 2000).  Accompanying a reduced IQ, 
individuals with DS display deficits on a range of learning and memory tasks, beginning 
at an early age.  Infants with DS display developmental learning delays in tasks such as 
the object-concept task and recognition memory tasks (Miranda & Fantz, 1974; Nygaard, 
Ludvig Reichelt, & Fagan, 2001).  As these individuals age, they display deficits in more 
complex memory tasks, including working memory tests (Jarrold, Baddeley, & Phillips, 
2002; Vicari, Bellucci, & Carlesimo, 2005).  Other types of memory deficits have been 
reported, including verbal short-term memory and spatial-spontaneous short-term and 
long-term memory tasks. (Frenkel & Bourdin, 2009; Lanfranchi et al., 2009; Lanfranchi, 
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Cornoldi, & Vianello, 2004; Vicari et al., 2005).  Individuals with DS also display 
performance deficits on tasks such as the virtual Morris water maze (MWM), CANTAB 
Pattern Recognition Memory Test, and the NEPSY List-Learning Test (Carlesimo, 
Marotta, & Vicari, 1997; Pennington et al., 2003).  These labratory tasks are commonly 
used to assess memory function because individuals with hippocampal damage show 
impairments on these tasks (Broadbent, Squire, & Clark, 2004; Goodrich‐Hunsaker et al., 
2010; Koehler et al., 1998).  The poorer performance on these tasks by individuals with 
DS suggest a phenotype that includes hippocampal dysfunction. 
Interestingly, some research suggests that visuospatial memory is somewhat 
preserved in individuals with DS.  For example, multiple studies have reported that 
children with DS do not display any deficits on a computer version of the Corsi block-
tapping task versus controls (Jarrold & Baddeley, 1997; Laws, 2002; Numminen et al., 
2001; Vicari, Carlesimo, & Caltagirone, 1995).  While these studies report an apparent 
preservation of visuospatial working memory, these studies do not represent a “real-
world” space; there is a lack of environmental and self-integration in solving the task.  
That is, these computerized assessments rely more on egocentric processing (self to 
object), rather than allocentric (object to object) processing.  Unlike egocentric memory, 
allocentric memory relies on the integration of multiple sensory systems, including the 
visual, vestibular and somatosensory systems. 
Mangan (1992) implemented a cue and place learning task in infants with and 
without DS.  In the cue learning task, infants were placed on a platform, and were shown 
two locations where a reward could be hidden.  However, only one rewarded location 
was used, thus, infants learned to always turn a certain direction towards the rewarded 
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location, in order to uncover a reward.  That reward was always covered with a colored 
lid, allowing the task to be solved with a visual cue (non-spatial processing).  The infants 
with DS required more trials than controls to solve the task.  However, they performed 
similar to controls in a final probe task.  In the place learning task, infants watched the 
reward being hidden in a hole on the platform, and then were placed in random start 
positions to search for the reward.  This task did not use a colored lid for reward 
indication, nor were the start positions consistent across training, thus, the infants had to 
use allocentric processing (position of the reward in relationship to environmental/wall 
cues).  In this task, the infants with DS were significantly impaired compared to controls, 
requiring more trials to learn the task, as well as a poor search pattern in the probe trial.  
  A more recent study implemented a similar procedure, a real-world spatial 
memory task in older, more developed individuals with DS.  In this study, participants 
were asked to locate three rewards hidden among 12 potentially rewarded locations.  
Cones were used to identify the reward locations by   On half of the trials, a cue (red cup) 
indicated where the reward was located, whereas the other half of trials there was no cue 
to indicate where the reward was hidden.  In the cued setting, individuals with DS were 
able to discriminate reward from non-reward locations at control levels.  However, in the 
non-cued setting, individuals with DS made fewer correct choices before making an 
error, visited more locations to find the three rewards, and had fewer correct first choices 
versus controls (Lavenex et al., 2015). 
Research has aimed to tie these memory deficits to the anatomical deficits; yet, 
this has yielded mixed results.  A negative correlation between parahippocampal gyrus 
size (measured via MRI) and cognitive ability has been suggested, as well as a direct 
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correlation between corpus callosum size and cognitive ability (Teipel et al., 2003).   
However, the same study reported no correlations between cerebral size, cerebellar 
hemisphere size, or hippocampal size and cognitive ability (Teipel et al., 2003).  
Connecting these memory deficits with the observed histological abnormalities would 
allow researchers to better understand the relationship between these two phenotypes of 
DS. 
 
1.1.4 The Ts65Dn mouse model of DS 
Mouse models of DS have been created to study the genotype-phenotype 
relationship observed in DS.  These models are based on the similarities between  Hsa21 
and mouse chromosomes 16 (Mmu16), Mmu17 and Mmu10 (Pletcher et al., 2001).  The 
most common models include Ts65Dn, Ts1Yey, Ts1Cje, Ts1Rhr, Ts1Yah, and the Tc1 
(Gardiner, 2010).  The models vary by how the triplicated genomic segment was created, 
the number of genes involved, as well as the degree of phenotypes exhibited.  The 
Ts65Dn mouse model contains ~140 genes that are highly conserved between Hsa21 and 
Mmu16 (Yamakawa, 2012).  The Ts65Dn mouse model is the most extensively studied 
and widely used animal model of DS because it replicates many of the DS phenotypes, 
including craniofacial and appendicular skeletal abnormalities, reduced birth weight, 
cardiovascular defects, cognitive and behavioral impairments, and brain defects (Baxter 
et al., 2000; Belichenko et al., 2004; Cooper et al., 2001; Reeves et al., 1995a).  Other 
mouse models, such as the Ts1Cje mouse, have been used for DS research, but its 
learning deficits are less severe than the Ts65Dn mouse (Sago et al., 2000b).  The Tc1 
model displays deficits in some learning and memory tasks (NOR) but not others 
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(spontaneous alternation t-maze).  Furthermore, these mice display variable levels of 
mosaicsm (O'Doherty et al., 2005; Rueda, Flórez, & Martínez-Cué, 2012).  While these 
and other mouse models are valuable in researching the variable phenotypes that are seen 
in DS, the Ts65Dn mouse model is the most commonly researched mouse model of DS. 
Ts65Dn mice have shown extensive impairments on learning and memory tasks 
(Demas et al., 1996, 1998; Reeves et al., 1995c).  Specifically, in NOR, Ts65Dn mice 
were less able to discriminate between a novel and a familiar object and displayed 
deficits in episodic memory functions (Fernandez et al., 2007).  Ts65Dn mice have also 
been shown to have significant deficits in the MWM spatial learning task with an 
increased latency (time taken to reach the platform) and reduced spatial navigational 
performance compared to euploid controls (Escorihuela et al., 1995; Hyde, Frisone, & 
Crnic, 2001; Reeves et al., 1995b; Sago et al., 2000a).  Ts65Dn mice have also shown an 
overexpression of the genes Olig1 and Olig2, which leads to an overproduction of 
inhibitory interneurons in the forebrain (Chakrabarti et al., 2010).  Hippocampal long 
term potentiation (LTP) is used as a model of synaptic plasticity that may engage similar 
cellular functional modifications, similar to those that occur during learning and memory 
(Morris, 2003).  Kleschevinok et al. (Kleschevnikov et al., 2004) used LTP to observe 
cell activity in the hippocampus of Ts65Dn mice.  They found that excessive inhibition of 
dentate granule cells (DGCs) limited the activation of NMDA receptors, therefore 
inhibiting LTP in vitro.   
Ts65Dn mice display neurohistological deficits during embryonic development.  
Starting on E13.5, Ts65Dn embryos have smaller telencephalons, but this deficit 
disappears by E18.5.  During this same time period, Ts65Dn mice displayed a decrease in 
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the subplate, cortical plate and the intermediate zone, however these layers reached 
control thickness by E18.5.  Despite normal thickness, there were reductions in cell 
density in all three areas.  A reduction in the hippocampal thickness was also observed 
during E13.5-E18.5.  Underlying these morphological deficits, is an observed deficit in 
cell cycle rate, specifically a longer S phase.  Interestingly, the difference in S phase 
cycle length between the Ts65Dn embryos and controls decreased with age.  
Furthermore, deficits of proliferation and cell migration were observed (Chakrabarti, 
Galdzicki, & Haydar, 2007).  While some of these deficits normalize, these results 
suggest that developmental delays are evident in Ts65Dn embryos.     
Postnatally, Ts65Dn mice exhibit deficits of the cell cycle in the developing 
cerebellum, as well as a decrease in cerebellum size, with decreased numbers of both 
granule and Purkinje cell neurons (Baxter et al., 2000; Contestabile et al., 2009; Roper et 
al., 2006).  Belichenko reported that Ts65Dn mice have synaptic abnormalities, including 
decreases in spine densities on the dendrites of DGCs (Belichenko et al., 2004).  .  
Deficits in hippocampal neurogenesis are also found in the Ts65Dn mouse.  Adult 
Ts65Dn mice have a decreased density of labeled cells in the cortex and DG, as well as a 
decrease in the number of neurons in the DG (Chakrabarti et al., 2007; Insausti et al., 
1998).  Deficits in cell proliferation have been observed at PD2 in Ts65Dn mice 
(Contestabile et al., 2007); similar results were reported at PD 15 (Bianchi et al., 2010c) 
and at 20-28 weeks (Insausti et al., 1998).  Proliferation deficits have also been seen in 
older Ts65Dn mice (10-12 months) (Llorens-Martin et al., 2010).  Recent research has 
focused on identifying the gene or set of genes that underlie these behavioral and 
anatomical deficits that are observed in DS and Ts65Dn mice.   
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1.2 The hypothesized role of DYRK1A in DS 
Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) are a 
family of protein kinases that phosphorylate serine and threonine residues in a number of 
substrates (Becker & Sippl, 2011).  DYRK1A is the only Dyrk in the family to be located 
on Hsa21, and is found in three copies in individuals with DS (Becker & Joost, 1999).  
An extra copy of DYRK1A has been shown to lead to a 1.5 fold increase (measured via 
Western Blot) in DYRK1A protein expression in various brain tissues of individuals with 
DS who were 10-40+ years old.  However, no differences in expression were observed in 
the infants with DS (1-3 years old).  This discrepancy suggests that DYRK1A may only be 
overexpressed during specific stages of development (Dowjat et al., 2007).   Dyrk1a is 
thought to play a key role in development because of its high expression in the CNS, and 
the severe deficits occurring both with increased or decreased expression levels (Martí et 
al., 2003).  In humans with a deletion of DYRK1A, microcephaly, intellectual disability 
and epilepsy have been observed (Bon & Hoischen, 2011; Courcet et al., 2012; Møller, 
Kübart, & Hoeltzenbein, 2008).   
A recent study examined induced pluripotent stem cells (iPSCs) derived from 
monozygotic twins discordant for DS and found evidence that DYRK1A contributes to 
developmental deficits.  Specifically, DYRK1A was overexpressed by approximately 
twofold in DS-iPSC-derived neural progenitor cells (NPCs), and when expression was 
reduced to normal levels (via a DYRK1A inhibitor and short hairpin RNA (shRNA)), 
previously observed neural proliferation and differentiation deficits were rescued 
(Hibaoui et al., 2014). 
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Dyrk1a protein levels were found to be  ~1.5 fold higher than euploid control 
levels in the cortex, cerebellum and hippocampus of Ts65Dn mice (Souchet et al., 2014).  
Numerous mouse models have been genetically modified in order to better understand the 
role Dyrk1a plays.  Dyrk1a knockout mice (Dyrk1a -/-) die prenatally, whereas mice with 
a copy reduction of  Dyrk1a (Dyrk1a +/-) display a wide range of abnormalities, 
including reduced viability, developmental delays, sensorimotor deficits, reductions in  
brain size, and deficits in cell structure (Altafaj et al., 2001; Benavides-Piccione et al., 
2004; Fotaki & Dierssen, 2002).  Interestingly, transgenic mice that overexpress Dyrk1a 
(TgDyrk1a) also express motor and learning deficits, similar to the mice with a reduction 
of Dyrk1a (Martınez de Lagrán et al., 2004).  These studies demonstrate that a balance of 
Dyrk1a copy number plays an important role in development.  Normalizing the 
expression level of Dyrk1a in mice has yielded convincing evidence for its role in CNS 
development.  For example, normalizing the copy number of Dyrk1a in the Ts65Dn 
mouse rescued deficits on the MWM, contextual fear conditioning, LTP, and 
proliferation deficits (Garcia-Cerro et al., 2014).  Gene targeting in TgDyrk1a and 
Ts65Dn mice using RNA interference via viral delivery (shRNA) inhibited and 
normalized Dyrk1a levels, and rescued Dyrk1a-mediated hyperactivity, motor deficits 
and some hippocampal-dependent behaviors (Altafaj, Martín, & Ortiz-Abalia, 2013; 
Ortiz-Abalia et al., 2008).  One month of environmental enrichment was also reported to 
normalize Dyrk1a kinase levels, improve acquisition and probe performance in the 
MWM, and increase swimming speed in female adolescent TgDyrk1a mice (Pons-
Espinal, Martinez de Lagran, & Dierssen, 2013). 
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1.3 Treatments targeting cognitive deficits in DS  
Treatments that have shown effectiveness in various diseases have been tested in 
mouse models of DS.  Memantine is a NMDA receptor antagonist that has been shown to 
normalize LTP in human brain slices and is used for the treatment of Alzheimer’s disease 
(Frankiewicz & Parsons, 1999; Reisberg et al., 2003).  Ts65Dn mice display abnormal 
(overactive) NMDA function (Scott-McKean & Costa, 2011).  Treatment with 
memantine (once a week injections for five consecutive weeks beginning at ~4-7 months 
of age and daily oral administration via drinking water for 3 consecutive weeks beginning 
at 9 months of age) improves MWM performance, grip strength, and contextual fear 
conditioning in Ts65Dn mice (Costa, Scott-McKean, & Stasko, 2008; Rueda et al., 2010).  
In a recent clinical trial called MEADOWS (Memantine for Dementia in Adults Older 
Than 40 Years With Down’s Syndrome), adults received daily oral memantine treatment 
(10mg/day) for one year.  However, memantine did not improve cognitive deficits.    
Ts65Dn mice demonstrate increase GABA inhibition, possibly resulting is 
reduced LTP (Kleschevnikov et al., 2004).  Treatment with pentylenetetrazole, a GABA-
A antagonist, improved performance on the MWM and restored LTP in the Ts65Dn 
mouse (Rueda, Florez, & Martinez-Cue, 2008).  Selective serotonin reuptake inhibitors 
have been shown to increase hippocampal neurogenesis (Malberg et al., 2000), and 
similar findings have been found in the Ts65Dn mouse, along with normalized GABA 
release, improved spatial memory, and hippocampal plasticity, and improved 
proliferation (Begenisic et al., 2014; Bianchi et al., 2010a; Bianchi, Ciani, & Guidi, 
2010b; Contestabile et al., 2012).  However, lithium and PTZ may not be the best 
potential therapeutic treatments for individuals with DS due to the risk of seizures and 
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toxicity (Prasher, 1993).  Another alternative treatment is maternal choline 
supplementation, which significantly improved the offspring’s performance in the MWM 
and hippocampal neurogenesis in the Ts65Dn mouse model (Velazquez et al., 2013). 
 
1.3.1 Is EGCG a potential treatment for DS? 
Epigallocatechin-3-gallate (EGCG) is the most prevalent polyphenol found in 
green tea (Sato & Miyata, 2000). EGCG is a small molecule hypothesized to improve a 
wide range of diseases, including cancer, Alzheimer’s disease, Parkinson’s disease, and 
multiple sclerosis (Choi et al., 2002; Kostoff, Briggs, & Lyons, 2008; Rezai-Zadeh, 
Shytle, & Sun, 2005).  One of the first studies showing the promise of EGCG was in 
cancer research.  Ahmad et al. documented that EGCG induced apoptosis and cell cycle 
arrest in cancer cells, without affecting normal cells (Ahmad et al., 1997).  EGCG has 
been shown to affect many factors associated with cell cycle progression, however, its 
inhibitory effect on kinases is considered a key feature.  Specifically, EGCG has been 
shown to inhibit the mitogen-activated protein kinase and the epidermal growth factor 
receptor-mediated pathway (Dong et al., 1997; Khan et al., 2006).  EGCG has also been 
shown to be an inhibitor of DYRK1A activity, and is thought to function by binding to 
the ATP binding domain of the protein and inhibiting its activity (Adayev, Chen-Hwang, 
& Murakami, 2006; Bain et al., 2003).  Consistent with its antioxidative properties, 
EGCG is known to undergo rapid degradation, with a concentration half-life in water of 
about 48 hours (Stringer et al., 2015).  Nonetheless, research suggests that EGCG has the 
potential as a therapeutic tool to improve the deficits seen in individuals with DS. 
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Oral administration of EGCG in drinking water (0.6-1.2 mg/day and 2-3 mg/day), 
respectively, to TgDyrk1a and Ts65Dn mice rescues learning and memory deficits, 
increases brain volume, rescues synaptic plasticity and proliferation deficits, and reduces 
Dyrk1a kinase activity (De la Torre et al., 2014; Guedj et al., 2009).   A three-week, low-
dose EGCG treatment (~10 mg/kg/day) during adolescence resulted in improvements in 
skeletal deficits in trisomic mice, but showed no improvements in a range of learning and 
memory tasks (Blazek et al., 2015; Stringer et al., 2015).  A similar dose (~9 mg/kg/day 
in capsule form) was used in a human study that showed improvements in cognition and 
more positive caregiver reports (De la Torre et al., 2014).  Administration of EGCG to 
induced pluripotent stem cells from an individual with DS not only reduced Dyrk1a 
activity, but rescued cell proliferation and differentiation deficits.  Importantly, the iPSC  
study established at a human cellular level that EGCG has the potential to improve some 
of the deficits seen in DS, such as cognitive and histological deficits (Hibaui et al., 2014).   
 
1.4 Initial hippocampal neurogenesis findings 
In 1913, Santiago Ramon y Cajal hypothesized that neurons in the brain are 
generated exclusively during prenatal development.  This idea was widely accepted until 
the 1950’s and 1960’s with the introduction of the use of tritiated thymidine, a 
radioactive deoxyribonucleoside that incorporates into DNA during the S (synthesis) 
phase of DNA replication.  Through autoradiography of tissues labeled with 3H 
thymidine, this method can serve as a marker for the timing of generation (“birthdate”) of 
new cells in the brain (Sidman, Miale, & Feder, 1959).  Studies from Joseph Altman, 
Gopal Das, and Shirley Bayer used 3H thymidine labeling and showed that neurons of the 
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dentate gyrus and olfactory bulb continued to be generated throughout life (Altman, 
Brunner, & Bayer, 1973; Altman & Das, 1965; Bayer & Altman, 1974).  The full 
contribution of these studies to postnatal neurogenesis was not fully appreciated until 
later, when the thymidine method was replaced with Bromodeoxyuridine (BrdU).  BrdU 
is a synthetic nucleotide of thymidine that can be incorporated into DNA and also used as 
a marker to identify cells that are undergoing replication during the S (synthesis) phase of 
DNA replication; (Gratzner, 1982; Nowakowski, Lewin, & Miller, 1989).   BrdU is more 
frequently used as it is cheaper, faster and more precisely localized in specific cells via 
immunocytochemistry and confocal microscopy.  When combined with other cell-
specific markers, it can confirm a cell’s phenotype (Abrous, Koehl, & Le Moal, 2005).  
The use of BrdU supported Altman’s original observations using thymidine (Kaplan & 
Bell, 1984; Kaplan & Hinds, 1977).  When BrdU was detected in neurons in postmortem 
brain sections in humans that had received an injection of BrdU for cancer treatment, this 
finding solidified the idea of adult postnatal neurogenesis occurring in both the rodent 
and mammalian brain (Eriksson et al., 1998). 
 
1.4.1 The hippocampal formation 
The hippocampal formation can be divided into four main regions; the DG, the 
Ammon’s horn of the hippocampus proper (CA1, CA2 & CA3), the subicular complex 
and the entorhinal cortex.  There are multiple connected pathways through the 
hippocampal formation.  One of the main projection pathways to the hippocampal 
formation is the perforant pathway from the entorhinal cortex to the dendrites of the DG 
granule cells (DGC).  The DGCs project to the CA3 region through the mossy fibers, and 
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pyramidal cells of the CA3 give rise to axons that either terminate within CA3 or project 
on to the CA1 region (Amaral & Witter, 1989).  The DG is thought of as the first 
“processing station” in the tri-synaptic loop (Piatti, Ewell, & Leutgeb, 2013).  The DG is 
composed of three main layers, the molecular layer, the granular layer and the 
polymorphic layer (Amaral & Witter, 1989).  The principal cell type in the DG is the 
granule cell, which gives rise to unmyelinated axons called mossy fibers that project to 
the CA3 (Amaral, Scharfman, & Lavenex, 2007).  While granule cells are excitatory, 
another cell type found in the DG, pyramidal basket cells, are inhibitory (Ribak & Seress, 
1983).  A third cell type is found in the DG, the mossy cell which typically resides in the 
hilus (Wenzel et al., 1997).  There are also numerous other connections through the 
hippocampus, such as direct connections from the entorhinal cortex to CA3 and CA1 and 
the commissural/associational projections from neurons in the hilus to the inner third of 
the molecular layer of the DG (Witter & Amaral, 1991).  Other studies have shown a 
direct “back projection” from area CA3 to mature and new granule cells (Vivar et al., 
2012).  The medial septal nucleus extends cholinergic projections throughout the 
hippocampus (Dragoi et al., 1999).  The hippocampus also receives inputs from the 
hypothalamus (Segal, 1979), as well as the contralateral hippocampus (Frotscher & 
Zimmer, 1983).   
 
1.4.2 The process of adult hippocampal neurogenesis 
Neurogenesis occurs in two areas of the adult rodent brain, the subventricular 
zone (SVZ) and the subgranular zone (SGZ) (Alvarez-Buylla & Lim, 2004).  Cells 
generated in the SVZ travel through the rostral migratory stream into the olfactory bulb 
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where they become interneurons (Lois, Garcia-Verdugo, & Alvarez-Buylla, 1996).  Cells 
born in the SGZ migrate into the granule cell layer of the DG and can differentiate into 
neurons, astrocytes, or oligodendrocytes (Mu, Lee, & Gage, 2010).  This differentiation is 
hypothesized to be dependent on astrocytes, as they have been shown to promote 
differentiation and integration of these progenitor cells in vitro (Song, Stevens, & Gage, 
2002).  As many as 9,000 new cells are generated per day in the rodent DG (Cameron et 
al., 1993; Kempermann, Kuhn, & Gage, 1997). 
There are two main types of cells that play a role in neurogenesis, neural stem 
cells (Type 1) that are self-renewing and multipotent-capable of giving rise to neurons, 
astrocytes or oligodendrocytes, and neural progenitor cells (Type II) (Gage & Temple, 
2013).  These type 1 stem cells give rise to type 2 cells through cell division, cells 
generated during this process are described as mitotic cells.  A subset of these type 2 cells 
commit to a progenitor cell state (neuroblasts), and can still divide and generate 
postmitotic immature neurons that are capable of becoming mature neurons.   Cells 
generated during this state are postmitotic cells (Aimone et al., 2014; Hodge et al., 2008).  
In order to better phenotype cells throughout these various stages of development, a 
number of immunohistological markers have been developed (und Halbach, 2007).   
During the initial proliferation stage, nestin, an intermediate filament protein, is 
commonly expressed in both neural stem cells and progenitor cells (Abrous et al., 2005).  
A majority of markers are used in conjunction with BrdU in order to better identify the 
specific stage of development the cells are undergoing (Abrous et al., 2005).  Ki-67 is 
commonly used in conjunction with BrdU, as this protein is present during all phases of 
the cell cycle, but is absent in quiescent cells (not dividing or preparing to divide) 
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(Scholzen & Gerdes, 2000).  Thus, Ki-67 can be used as a marker for proliferation.  
Another common proliferation marker is glial fibrillary acidic protein (GFAP).  
Progenitors that express GFAP has been shown to generate the majority of neuroblasts 
and neurons, thus it can be used as a marker for proliferation (Garcia et al., 2004).   
However, GFAP is also expressed in mature astrocytes (und Halbach, 2007), so 
morphological assessments should be taken to distinguish between a progenitor cell, and 
an astrocyte. 
A subset of type 2 cells daughter cells will become post-mitotic and begin to 
differentiate. Initially, these cells continue to be nestin-postive, but are GFAP-negative 
(Kronenberg et al., 2003).  Shortly thereafter, cells become nestin-negative, and double 
cortin (DCX) expression, a microtubule binding protein, becomes a prominentmarker.  
DCX is highly expressed in proliferating progenitors and differentiating neuroblasts, but 
becomes undetectable approximately two months after labeling with BrdU.  However, 
DCX can be co-expressed in cells that also express NeuN (nuclear neuronal marker), a 
common marker for mature neurons, for a period of time.  Thus, there can be overlap of 
DCX and NeuN expression and it has been suggested that DCX labels both mitotic and 
postmitotic (differentiating) neurons (Brown et al., 2003).  Poly-sialylated-neural cell-
adhesion molecule (PSA-NCAM) is also used, as it is highly expressed in progenitor cells 
and PSA-NCAM labeled cells commonly express other markers specific to this stage, 
such as DCX or NeuN (Seki, 2002).  During this phase, transcription factors such as 
Olig2 and Pax6 have been shown to positively regulate progenitor differentiation (Hack 
et al., 2005).  Growth factors, such as brain derived neurotrophic factor (BDNF) and 
signaling pathways, like the sonic hedgehog pathway (SHH), have both been shown to 
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regulate both proliferation and differentiation of cells (Chen et al., 2013; Rowitch et al., 
1999).  The Wnt pathway has also been shown to regulate progenitor cell proliferation 
and differentiation, possibly by upregulating NeuroD1 expression, which is a crucial 
transcription factor for proliferation and differentiation (Lie et al., 2005).   
Cells that have a determined neuronal-fate then begin a process of migration and 
functional integration into the DG. During this cell survival stage, PSA-NCAM and DCX 
are still commonly used as markers.  These cells retain an immature phenotype for 
approximately four weeks while they undergo both a morphological and physiological 
maturation process (Zhao, Deng, & Gage, 2008).  The migration of these cells to the 
inner granule cell layer is thought to be regulated by disrupted-in-schizophrenia (DISC1), 
as downregulation in this protein results in accelerated integration (Duan et al., 2007).  
Functionally, these newborn cells are initially depolarized by GABA, but this response 
switches to hyperpolarization around 2-4 weeks of age.  At this stage of depolarization, 
these cells have been shown to have lower thresholds for LTP, resulting in increased 
potentiation, and plasticity (Ge et al., 2007).  Mossy fiber endings establish contact with 
CA3 pyramidal cells around two weeks of age, and these endings increase in size and 
complexity over time (Taupin, 2007).  While able to become depolarized by GABA, 
these cells are still relatively inactive, firing few action potentials (Vivar et al., 2012).  
Around two weeks of age is a crucial time point for these neurons, with around 50% 
being lost in the maturation process (Dayer et al., 2003).  At three weeks of age, the 
dendrites of these cells reach the outer molecular layer, and GABA has now become 
hyperpolarizing (Ge et al., 2006).  At four weeks of age, dendritic branching and mossy 
fiber outputs become more complex (Zhao et al., 2006).  These cells are considered 
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mature around six weeks of age, and are commonly phenotyped using calbindin, a 
neuronal calcium-binding protein, as well as NeuN, a neuronal specific nuclear protein 
that is found in the nucleus of postmitotic neurons (Mullen, Buck, & Smith, 1992; 
Sloviter, 1989; Zhao et al., 2006). 
 
1.4.3 The role of neurogenesis in learning and memory 
The process of neurogenesis can be influenced by ex vivo factors as well.  
Environmental enrichment and running have been shown to increase hippocampal 
neurogenesis (Kempermann et al., 1997; Tashiro, Makino, & Gage, 2007; Van Praag, 
Kempermann, & Gage, 1999).  Conversely, aging and stress have been shown to have a 
negative effect on neurogenesis (Cameron & Mckay, 2001; Warner‐Schmidt & Duman, 
2006).  Learning can also increase neurogenesis, but this may be limited to specific tasks.  
Hippocampal-dependent tasks, such as trace eye blink conditioning or spatial navigation 
tasks, increase the survival of new neurons, specifically those that were generated before 
training.  However, tasks that are not hippocampal-dependent (e.g., delay eyeblink 
conditioning; visually-cued navigation) do not have an effect (Gould et al., 1999).  
Interestingly, a study that found a positive effect of running on neurogenesis through 
promotion of rates of proliferation, did not find the same effect when mice were trained 
on the MWM, a seemingly hippocampal-dependent task (Van Praag, Kempermann, & 
Gage, 1999).  Importantly, this contrasts with the abovementioned study that did find an 
increase in survival of newly generated neurons after MWM training.  These contrasting 
studies prompted the idea of a “critical period” for experience-dependent neuron survival, 
since the studies labeled neurons at different time points.  Subsequent studies showed that 
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experiences or learning episodes occurring 3-4 weeks after neuronal birth had the greatest 
effect on neuronal survival and integration into functional hippocampal circuits (Kee et 
al., 2007; Tashiro et al., 2007). 
Early studies focused on identifying a role for the hippocampus in learning and 
memory tasks.  Lesions of the hippocampus result in performance deficits on numerous 
tasks (delayed nonmatching to sample, MWM, contextual fear conditioning, and trace 
eye blink conditioning), suggesting that this structure is crucial for these hypothesized 
hippocampal-dependent tasks (Eichenbaum, Stewart, & Morris, 1990; Salmon, Zola-
Morgan, & Squire, 1987; Weiss et al., 1999).  However, subsequent studies focusing on 
ablating neurogenesis, suggested that the integrity of adult hippocampal neurogenesis 
was not necessary for performance on some hippocampal-dependent tasks.  Ablation of 
postnatal neurogenesis did not impair performance on previously reported hippocampal-
dependent tasks, such as contextual fear conditioning, MWM, the Y-maze task, or NOR 
(Madsen et al., 2003; Saxe et al., 2006; Shors et al., 2002).  These results suggested that 
the generation of new neurons is not necessary for performance on some hippocampal-
dependent tasks.  For example, the monosynaptic pathway (ECCA1), bypassing the 
DG, is sufficient to learn the MWM task (Brun et al., 2002; Nakashiba et al., 2008).  
These findings were followed by an extensive series of studies aiming to elucidate the 
specific functional role of adult-born neurons in behavior. 
 
1.5 What role do newborn neurons have in behavior? 
DGCs receive direct inputs from the entorhinal cortex, which has been described 
as a very active network, and its neural representation (approximately 200,000 cells in the 
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adult rat) is projected to a much larger number of DGCs (Amaral, Ishizuka, & Claiborne, 
1990; West, Slomianka, & Gundersen, 1991).  The encoding scheme in the DG has been 
described as “sparse” because even with a high number of activated neurons, the 
proportion of active nuerons is relatively low due to the large number of cells in the DG 
(approximately 1,000,000)  (Piatti et al., 2013).  Interestingly, only 1-2% of these cells 
are active during behavioral exploration (Tashiro et al., 2007).  These characteristics of 
the DG are in stark contrast to the entorhinal cortex, which has high levels of active 
neurons and mean firing rates of neurons (Barnes et al., 1990).  The DG has also been 
described as “sparse” because activity levels in the DG are lower than its main input (EC) 
as well as its main output (CA3).  Thus, the DG has lower activity than the afferent inputs 
and the target neuronal population (Yassa & Stark, 2011).  A sparse representation is 
hypothesized to be crucial for memory encoding, as this allows information to be 
encoded in a distinct, non-overlapping manner  (Yassa & Stark, 2011).  Thus, combined 
with its unique physiological properties and location within the hippocampal formation, 
newly generated DGCs are hypothesized to play a key role in this encoding, called 
“pattern separation” (Yassa & Stark, 2011).   
These distinct representations allow, at a behavioral level, discrimination between 
similar memories acquired during learning (Yassa & Stark, 2011).  It is important to note 
the type of information that the DGCs process during pattern separation.  These new 
granule cells receive input from the lateral entorhinal cortex and perirhinal cortex (PRH), 
whereas mature cells receive innervation from both the lateral entorhinal cortex and 
medial entorhinal cortex (Vivar & Van Praag, 2013).  The lateral entorhinal cortex and 
perirhinal cortex are thought to transmit non-spatial information about the environment, 
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including familiarity, whereas the medial entorhinal cortex is thought to process more 
spatial-based information (Deshmukh & Knierim, 2011; Hafting et al., 2005).  A 
diminished PRH has been shown to correlate with impairments in distinguishing between 
objects with similar, overlapping features (Burke et al., 2011).  This suggests that 
newborn granule cells innervated by the lateral entorhinal cortex/perirhinal cortex may be 
more specific for processing and separating familiar environmental information versus 
mature granule cells.  
 
1.5.1 Evidence for the role of newborn neurons in pattern separation 
Behavioral pattern separation can be assessed using multiple methodological 
approaches, including a contextual fear discrimination task.  In this task, animals are 
trained to associate an aversive stimuli (foot shock) with a specific, neutral context.  
When the animal is placed into a similar context, freezing indicates a lack of context 
discrimination in the animal, whereas exploration would indicate the recognition of the 
novel context (Kheirbek et al., 2012).  Another method that is commonly used is an 
automated touchscreen operant chamber.  This touchscreen version of pattern separation 
trains animals to discriminate between locations on a screen, with varying distances as 
the manipulation. (Josey & Brigman, 2015; McTighe et al., 2009; Talpos et al., 2010).  A 
third method for measuring behavioral pattern separation is a delayed non-matching to 
sample radial arm maze task.  In this task, the animal is first exposed to a start arm and a 
forced reward arm.  After a short delay, the mouse is placed in the same start arm 
position, with the original and a novel arm (now reward arm) both open.  The location of 
the novel arm is manipulated by varying its distance from the original forced arm.  It is 
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proposed that it is a more difficult task when the novel arm is close to the forced arm 
(≤90 degrees), versus a 180 degree separation (Clelland et al., 2009a). 
In order to understand the role of DGCs in these pattern separation tasks, multiple 
studies have examined the relationship between the manipulations of these cells, and 
subsequent performance on a pattern separation task.  Early approaches for ablating 
neurogenesis included using Methylazoxymethanol acetate (Maeda-Yamamoto et al.), x-
irradiation and ionizing radiation (Altman, 1969; Johnston & Coyle, 1979; Peißner et al., 
1999).  These methods are effective at reducing neurogenesis;  however, some animals 
are still able to learn some of the hippocampal-dependent tasks, and observed 
impairments may have been confounded by aversive or toxic side effects (Dupret et al., 
2005; Groves et al., 2013; Madsen et al., 2003; Saxe et al., 2006; Shors et al., 2002; 
Urbach et al., 2013; Hernandez-Rabaza et al., 2009).  While some of these techniques 
continue to be used, more genetically targeted techniques have been implicated to study 
pattern separation.  The DNA methyl transferase type 1 (DNMT1) gene is necessary for 
cell viability.  By crossing DNMT1-cKO mice with either DNMT1-loxP/mGFAP-Cre-
negative or DNMT1-loxP/mGFAP-Cre-positive mice, half of the offspring would be 
DNMT1-loxp/mGFAP-Cre-positive.  Thus, these animals would lack DNMT1 in cells 
expressing GFAP (adult neuroprogenitors, thus neurogenesis is prevented) (Cushman et 
al., 2012).  DNMT1-loxP/mGFAP-Cre-positive mice were impaired relative to controls 
in a spatial pattern separation task.  However, they were not impaired versus controls in 
an object-context recognition or a spatial location recognition task, suggesting that the 
function of newly generated cells are crucial for pattern separation tasks (Kesner et al., 
2014).  Ablating neurogenesis using x-irradiation or gene knockout techniques (ablating 
25 
 
 
2
5
 
FMRP expression in NSCs) has also been shown to significantly impair pattern 
separation task performance in the radial arm maze task (Nakashiba et al., 2012), as well 
as performance in a contextual discrimination task (Nakashiba et al., 2012; Tronel et al., 
2012).  Conversely, increasing neurogenesis has been shown to improve pattern 
separation performance.  Ablation of Bax (a pro-apoptotic gene) significantly increased 
postnatal neurogenesis and performance on a contextual fear task (Sahay et al., 2011).  
Physical exercise (via running wheel) improves performance on smaller separations in a 
touch-screen spatial pattern separation task, and this improvement was also correlated 
with increased neurogenesis (Creer et al., 2010).   
The utilization of a behavioral pattern separation task in the Ts65Dn mouse model 
could allow researchers to directly correlate a specific Ts65Dn deficit (adult 
neurogenesis) to a specific behavioral outcome (performance on a pattern separation 
task).  This type of correlation would be invaluable for research that is targeting 
improvement of the cognitive deficits that are observed in DS.  Not only would this task 
increase the phenotype resolution for the Ts65Dn mouse model, but it would allow 
researchers to administer targeted treatments (to improve neurogenesis deficits) with the 
reliance of a direct behavioral measure.  With the increasing use of EGCG as a potential 
therapeutic treatment for the cognitive deficits in DS, examining the effects of EGCG on 
pattern separation performance, and concurrently on adult neurogenesis in the Ts65Dn 
mouse model is an important study for DS research. 
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1.6 Thesis Hypotheses 
HYPOTHESIS 1: Trisomic mice would be impaired on smaller degrees of separation in a 
spatial pattern separation task versus controls, and that EGCG treatment would 
ameliorate these deficits. 
HYPOTHESIS 2:  Trisomic mice would display deficits in adult hippocampal 
neurogenesis, and that EGCG would increase neurogenesis of Ts65Dn mice by 
promoting cell proliferation, survival, or both.  
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CHAPTER 2. METHODS 
2.1 The effect of EGCG on a pattern separation task in the Ts65Dn mouse 
 
2.1.1 Ts65Dn Housing 
Female B6EiC3Sn a/A-Ts(1716)65Dn (Ts65Dn), C57BL/6J (B6) and 
C3H/HeJ(C3H) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). 
The B6C3F1 mice were bred by crossing B6 and C3H males and females. Ts65Dn 
females (approximately 50% B6 and 50% C3H background with small trisomic marker 
chromosome) were bred to B6C3F1 males to generate the mice used in the study.  Pups 
were born following 19-21 days of gestation.  On PD 6-10, tissue was obtained and DNA 
isolated for genotyping by PCR.  Only male mice were used in this study due to the sub 
fertile nature of the Ts65Dn males and the importance of females in colony maintenance.  
Ts65Dn and euploid (control) male offspring were weaned on PD21, and singly housed 
in a climate-controlled room on PD 22.  Housing was maintained on a reverse light/dark 
cycle, so that testing would occur during the active (dark phase) of the circadian cycle.   
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2.1.2 Mouse Genotyping by PCR 
All mice born into the colony were genotyped using the breakpoint PCR 
(Reinholdt et al., 2011).  The breakpoint PCR makes use of a Chr17fwd primer 
(GTGGCAAGAGACTCAAATTCAAC) and Chr16rev primer
(TGGCTTATTATTATCAGGGCATTT) set to amplify a ~275 bp product at the 
translocation point on 1716 murine chromosome and a positive control primer set of 
IMR1781 (TGTCTGAAGGGCAATGACTG) and IMR1782 
(GCTGATCCGTGGCATCTATT) that amplifies a 544bp product. The final PCR mix 
contained 10X reaction buffer, dNTPs, MgCl2, Taq polymerase, water, two sets of 
primers, and DNA. The PCR cycling conditions were set to 94°C for 2 minutes to 
initialize the reaction, followed immediately by 45 seconds at 94°C to melt the template 
DNA in a denaturation step that yields single stranded DNA molecules. The template 
DNA was then cooled down to 55°C for 45 seconds to allow annealing of the primers to 
the template, and strand elongation to occur through the action of Taq polymerase at 
72°C for 1 minute. The denaturation, annealing and elongation steps were repeated for 34 
cycles and were followed by a final elongation step for 7 minutes at 72°C. To verify the 
PCR products, the samples were separated on a 1.5% agarose gel made by dissolving 
0.75 g of agarose in 50 mL 1X TAE buffer.  
The size(s) of PCR products were determined by comparison with a DNA ladder, 
which contained DNA fragments of known size, run alongside the products on the gel. 
This is a crucial step in our studies as it is important to positively distinguish trisomic 
Ts65Dn mice from the euploid mice. The repeated backcrossing of the Ts65Dn females 
to B6C3F1 males would lead to approximately 25% of all Ts65Dn pups born with this 
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background to be homozygous for the C3H-derived retinal degeneration mutation 
Pde6brd1  that causes blindness within the first few weeks of life (Costa et al., 2010). 
Therefore, all mice born in to the colony were screened for retinal degeneration (Rd) 
(Jackson, 2007).  
The PCR mix contained 10X KCl reaction buffer, MgCl2, dNTPs, primers- 
IMR2093 (AAgCTAgCTgCAgTAACgCCATTT- 560 bp), IMR2094 
(ACCTgCATgTgAACCCAgTATTCTATC- 240 bp), IMR2095 
(CTACAgCCCCTCTCCAAggTTTATAg- 560 and 240 bp), water and Taq polymerase 
enzyme. The Rd PCR utilized three separate primers to identify the mice that are 
heterozygous (rd/+), homozygous for the mutation (rd/rd), or wild type (+/+). The 
reaction was initialized by holding the samples at 94°C for 5 minutes, immediately 
followed by 30 seconds at 94°C to melt the template DNA in to single strands of DNA.  
The template DNA was then cooled down to 65°C for 30 seconds to facilitate the 
attachment of primers to the template, and strand elongation was performed through the 
action of Taq polymerase at 72°C for 1.5 minute. The denaturation, annealing and 
elongation steps were repeated for 35 cycles and were followed by a final elongation step 
for 2 minutes at 72°C. The PCR products were held at 10°C until they were separated on 
a 1.5% agarose gel. Only heterozygous (rd/+) and wild type (+/+) male mice were 
utilized in this study. 
 
2.1.3 EGCG preparation 
EGCG, obtained from Sigma Aldrich (EGCG, <95%), was chosen as the standard 
treatment due to its high level of purity. A stock solution of 15 mg/mL was made by 
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dissolving 30 mg of solid EGCG in 2 mL of PBS and was refrigerated to maintain 
stability. Treatments of 0.4 mg/mL concentration were prepared by diluting the stock 
solution in tap water.  The pH of the EGCG and water (control) treatments were 
established using phosphoric acid (pH 5-5.5).    
On PD22, trisomic and euploid mice were randomly assigned to the EGCG 
condition (dissolved in drinking water with concentration of 0.4 g/ml EGCG stabilized 
with phosphoric acid to pH 5.5) or to the control condition (water with phosphoric acid).  
Fluid consumption was measured every other day when fluids were refreshed.  Treatment 
was ongoing throughout the experiment. 
 
2.1.4 Timeline 
Mice were placed into either the cell survival or cell proliferation study.  On PD 
55, all mice were covered and brought to the injection room.  Each mouse was handled 
for 2 minutes under red light, then was covered and brought back to the housing room.  
On PD60-PD63, mice were brought back to the same room, and received a 50mg/kg 
intraperitoneal (i.p.) injection of either BrdU (cell survival study) or saline (cell 
proliferation study).  After injections were complete, mice were covered and brought 
back to the housing room.  Each mouse received a single injection for four consecutive 
days.  On PD64-PD70, mice were weighed, and food restricted daily to 85% body 
weight.  Restricted weights were increased by 2% every week to prevent inhibition of 
natural growth.  Mice were handled during the food restriction week in the pattern 
separation testing room.  After the food restriction week, habituation and testing (20 total 
days) began in the pattern separation task.  At the end of testing, the cell survival animals 
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were perfused under deep anesthesia with 4% paraformaldehyde.  Brains were carefully 
removed from the skull and placed in 4% paraformaldehyde.  Cell proliferation animals 
received ad libtum access to food for approximately 6 days.  They then received a single 
i.p. injection of 100 mg/kg of BrdU (Sigma, 10mg/ml concentration in 0.9% sterile 
saline) to label dividing progenitor cells.  Two hours later, mice were perfused under 
deep anesthesia with 4% paraformaldehyde.  Brains were carefully removed from the 
skull and placed in 4% paraformaldehyde.  Coronal sections through the hippocampal 
formation were stored at -20C in a cryoprotectant solution containing glycerol and 
ethylene glycol in Trisbuffer solution for 48 hours.  The slices were then processed for 
peroxidase immunohistochemistry to label BrdU+ cells.  All experimentation was carried 
in accordance with Indiana University-Purdue University Indianapolis School of Science 
IACUC. 
 
2.1.5 5-Bromo-2-hydroxyuridine preparation 
5-Bromo-2-hydroxyuridine (B5002 Sigma) was stored at 4° C until ready for 
preparation.  0.9% sterile saline solution was warmed to approximately 50° C.  5-Bromo-
2-hydroxyuridine (concentration 10mg/ml) was removed from the freezer and measured 
on an analytical scale.  Bromo-2-hydroxyuridine was then added to a 2ml tube and warm 
saline was slowly added via syringe.  The solution was gently vortexed, and was used 
immediately for injections. 
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2.1.6 Pattern Separation Training 
The testing apparatus was an eight arm radial maze composed of white Plexiglas.  
The arms were 76.2 cm long, 7.62 cm high and 0.635 cm thick.  The center octagon was 
20.9 cm wide, with eight doors for each arm standing 8.25 cm tall.  The maze was placed 
on a sheet of plywood, which rested on top of a cart 87.63 cm above the ground.  The 
center of the maze was placed 114.3 cm from the wall, and visual cues and curtains 
surrounded the maze.  The mice underwent four days of habituation before testing began.  
A picture of the testing apparatus is seen in Figure 2.1. 
1. Habituation Day 1-On the first day, the mice were brought to the testing room 
and were allowed to individually explore the maze for 10 minutes.  Three fruit 
loops were placed in each arm at 10cm, 20cm and 30cm away from the center 
octagon.  At the end of each arm (30cm), blue 15mL caps held a piece of fruit 
loop (approximately .05 grams).  After ten minutes, the mouse was returned to 
the homecage, the maze cleaned, and new fruit loops were placed in the maze 
for the next mouse.   
2.  Habituation Day 2 and 3-A piece of fruit loop was only placed in the wells at 
the end of each arm (8 total food pellets).  The mice were allowed to explore 
for 10 minutes, or until all the fruit loops were retrieved.  By the third day, all 
mice were retrieving fruit loops from at least 6 arms.   
3. Habituation Day 4- The mice were given four forced trials.  Each arm was 
blocked off except for a start arm and a sample arm.  Four random start arms 
were chosen by the experimenter.  The sample arm position (left or right of 
start arm) was counterbalanced across the four trials.  These four days of 
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habituation ensured that the mice were motivated by the presence of fruit 
loops, and that anxiety levels were at a minimum.   
On day five, testing began with 6 trials (sample + choice).  Mice were tested on a 
delayed nonmatching to place radial arm maze task, adapted from (Clelland et al., 
2009b).  Mice were tested on their ability to select, from a choice of two arms, the arm 
location that had not been presented in the previous trial.  During the sample phase, all 
arms except a start arm and a sample arm were closed off.  The mouse was placed in the 
start arm and was allowed to retrieve a food reward from the sample arm.  The mouse 
was then removed from the maze and placed in its home cage.  The start, sample and 
choice arm were then wiped with 70% ethanol to prevent olfactory cues.  The choice arm 
was no longer blocked off, and now contained the fruit loop. The cleaning took 
approximately 20-30 seconds.  The mouse was then placed in the start arm, and was now 
forced to choose between the sample (unrewarded) and the choice (reward) arm.  The 
choice arm varied in distance from the sample arm by a separation of 1, 2 or 3 arms.  A 
mouse was determined to make a correct choice by entering and retrieving the fruit loop 
from the choice arm.  If a mouse made an incorrect choice (enters the sample arm), the 
mouse was allowed to self-correct and retrieve the fruit loop from the choice arm.  The 
mouse was then removed from the maze, and all arms were thoroughly cleaned.  All 
other mice were tested on the same separation before the first mouse began the second 
trial.  Mice underwent six trials (sample plus choice phases) per day of pseudo randomly 
presented combinations of start plus sample plus correct arms for 18 consecutive days (36 
trials of each separation).  A summary of the study timeline is seen in Figure 2.2. 
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2.1.7 Statistics 
For the pattern separation acquisition, the average three-day percentages were 
analyzed using a mixed analysis of variance (ANOVA) with genotype and treatment as 
between-group factors and Day (3 day blocks) as a repeated measure.  For the separation 
analysis, a mixed ANOVA with genotype and treatment as between-group factors and 
separation (3 degrees) as a repeated measure was used.  
 
2.2 The effect of EGCG on proliferation in the dentate gyrus of the Ts65Dn mouse  
 
2.2.1 Tissue collection 
 Animals assigned to the cell proliferation study received ad libtum access to food 
for approximately 6 days.  They then received a single i.p. injection of 100 mg/kg of 
BrdU (Sigma, 10mg/ml concentration in 0.9% sterile saline) to label dividing progenitor 
cells.  Two hours later, mice were perfused under deep anesthesia with 4% 
paraformaldehyde.  Brains were carefully removed from the skull and placed in 4% 
paraformaldehyde for 24 hours.  Brains were sliced coronally at 40 µm beginning at 
Bregma -1.22 mm and ending at -2.18 mm (Figure 2.3).  Coronal sections through the 
hippocampal formation were stored at -20o C in a cryoprotectant solution containing 
glycerol and ethylene glycol in Trisbuffer solution for 48 hours.  The slices were then 
processed for peroxidase immunohistochemistry to label BrdU+ cells.   
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2.2.2 Immunohistochemistry 
For the peroxidase immunohistochemistry, sections were washed in TBS (0.15 M 
NaCl and 0.1M Trizma HCl) and treated with 3% H2O2 for 10 minutes to block 
endogenous peroxidases.  Then, the slices were washed 5x2 min in TBS, and underwent a 
30 minute incubation in 2N HCl at 37ºC.  Sections were then washed in 0.1M Boric acid 
(pH=8.6) in TBS, in TBS alone, incubated for 1 hour in blocking solution (0.5% Triton 
X-100 and 3% normal goat serum in TBS), and then incubated with the primary antibody 
solution (rat anti-BrdU, 1:500; Accurate Chemical, OBT0030) for 48 hours at 4ºC.  
Following primary antibody incubation, sections were washed in the blocking solution, 
followed by a 1 hour incubation in the blocking solution.  The slices were then washed 3 
times in TBS, and were incubated in the secondary antibody (biotinylated anti-rat made 
in goat, 1:250; Vector Laboratories, BA-9400), then for 1 hour in avidin-biotin-
peroxidase complex solution (ABC Elite Kit; Vector Laboratories, PK-4000) with nickel-
enhanced diaminobenzidine as the chromagen.  Slices were mounted to slides and 
allowed to dry for 48 hours.   
 
2.2.3 Tissue Staining and Counting 
Slides were briefly dipped in milli-q water, and then placed in a 0.5% Methyl 
green solution (Sigma-Aldrich) for seven minutes.  This was followed by 2 x 20 second 
slow dips in water.  Slides were then placed in 70% ethanol for approximately 1 minute, 
with slices being monitored for differentiation.  This was followed by a 5 second dip in 
95% ethanol, then a 1 minute dip in 100% ethanol.  Finally, slides were left in xylene for 
5 minutes, and then the counterstained slides were coverslipped with Permount.  Slides 
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were left to dry for 48 hours.  Quantification of BrdU cells was done similar to previous 
studies (Malberg et al., 2000; Eisch et al., 1999).  BrdU+ labeled cells were counted in 
the subgranular layer of the DG with a bright-field microscopy camera (Nikon), at 1000x 
magnitude with the 100x oil objective (Figure 2.4).  The volume of the granule cell layer 
was quantified by the 4x objective, using Cavalieri’s principle (Stereologer system and 
software; Systems Planning and Analysis, Inc., Alexandria, VA).  Section thickness was 
measured using a 1000x magnification.  
 
2.2.4 Statistics 
Cell counts were analyzed with a 2-way factorial ANOVA.  The primary 
hypothesis would be confirmed if EGCG treatment significantly increased the number of 
BrdU+ cells in the subgranular zone of the DG of the trisomic mice. 
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CHAPTER 3. RESULTS 
3.1 The effect of EGCG on pattern separation testing in the Ts65Dn mouse   
 
3.1.1 Ts65Dn growth and EGCG consumption 
 Trisomic mice weighed significantly less than the euploid mice (Figure 3.1), 
confirmed by a main effect of genotype [F(1,61)=31.33, p=<0.001].   However, both 
groups increased their weight as a function of time [main effect of day, F(24,1464)= 
272.602, p=<0.001].  As shown in Figure 3.2, EGCG consumption for both groups was 
average approached 70 mg/kg per day in the first week, then decreased their consumption 
over time to stable levels around 50 mg/kg/day [main effect of day, F(25,1025)= 16.629, 
p=<0.001].  Importantly, there were no significant differences in EGCG consumption 
between the euploid and trisomic mice  
 
3.1.2 Ts65Dn pattern separation performance 
 Prior to pattern separation, mice either received an injection of saline (cell 
survival study) or BrdU (cell proliferation study).  Of the 65 animals presented here, 44 
received an injection of BrdU and 21 received a saline injection.  There were no effects 
of BrdU on subsequent performance in the pattern separation task (p=0.135). 
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As shown in Figure 3.3, euploid and trisomic groups increased their overall 
performance over the course of training [main effect of day, F(5,305)= 4.6, p=<0.001].  
However, euploid mice had a higher overall performance versus the trisomic mice, [main 
effect of genotype. F(1,61)= 18.435, p<0.001].  No interactive effects were found.  For 
separation performance (Figure 3.4), both euploid and trisomic mice increased their 
performance as a function of separation, [main effect of separation F(2, 122)= 20.541, 
p<0.001].  Euploid mice had an overall higher performance on each separation versus the 
trisomic mice [main effect of genotype F(1,61)=21.277, p<0.001].  No main or 
interactive effects of EGCG treatment were found.  To identify differences in 
performance as a function of the degree of arm separation, the euploid + water (control) 
animals were assessed with a paired samples t-test between each of the three degrees of 
separation.  As shown in Table 3.1 and Figure 3.4, the euploid animals made significantly 
fewer correct choices in separation 1 versus separation 2 (p=0.001) and in separation 1 
versus separation 3 (p=0.001).    They were not significantly different between separation 
2 versus separation 3 performance (p=0.524).  For the trisomic + water animals, 
performaning significantly worse in separation 1 compared to separation 2 (p=0.006).  
However, there were no differences in performance when comparing separation 1 versus 
separation 3 (p=0.09), nor when comparing separation 2 versus separation 3 (p=0.209) 
(Table 3.1). 
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3.2 The effect of EGCG on proliferation in the dentate gyrus of the hippocampus 
 
3.2.1 Ts65Dn dentate gyrus proliferation 
 There were no significant differences between euploid and Ts65Dn mice in the 
density of BrdU-labeled cells [F(1,18)= 0.896, p=0.356], the average section thickness 
[F(1,18)= 0.586, p=0.454], the average volume per section [F(1,18)=1.10, p=0.308], the 
number of sections counted [F(1,18)= 1.88, p=0.187], or the total reference volume 
[F(1,18)= 2.149, p=0.160].  There was a main effect of genotype of the total number of 
labeled cells [F(1,18) = 8.83, p=0.008], as indicated by the higher number of cells 
counted in the euploid versus trisomic mice (Table 3.2 & Figure 3.5). 
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CHAPTER 4. DISCUSSION 
4.1 Ts65Dn performance on a pattern separation radial arm maze task 
This study is the first to test the Ts65Dn mouse model in a pattern separation task, 
and demonstrated that Ts65Dn mice exhibit deficits in acquisition in the pattern 
separation task that was evident across all three degrees of separation.  These deficits 
were not alleviated with a seven week treatment of EGCG administered via drinking 
water [0.4mg/ml; ~50mg/kg/day].  Previous work in our and other labs have shown that 
Ts65Dn mice and individuals with DS exhibit deficits on tasks that are thought to rely on 
the hippocampus, such as MWM, NOR, and the T-maze task (Pennington et al., 2003; 
Reeves et al., 1995c; Stringer et al., 2015).  The utilization of this pattern separation task 
provides a novel learning task consistent with the phenotypic profile of Ts65Dn mice.   
This task used three degrees of separation, with separation 1 having the highest 
degree of similarity to the just-experienced forced choice, thus requiring finer-grain 
pattern separation in order to discriminate and correctly choose the rewarded arms.  
Separations 2 and 3 were less similar to the just-experienced forced choice, and 
hypothesized not to rely as much on pattern separation in order to make the correct 
choice.  Ts65Dn mice had an overall deficit on all three separations, rather than a deficit 
on just the subtly different arm presentations.  There are a few factors that could be 
contributing to these findings.  Ts65Dn mice display multiple hippocampal deficits, not 
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just in adult hippocampal neurogenesis (Lorenzi & Reeves, 2006).  This is important to 
note because during pattern separation tasks, the DG is not the only structure that is 
active (Yassa & Stark, 2011).  For example, more distinct discriminations (separations 2 
and 3) are hypothesized to not require pattern separation encoding, rather, relying on the 
ECCA3 pathway (Neunuebel & Knierim, 2014).  Ts65Dn mice have also been shown 
to display deficits in synaptic density and the synapse to neuron ratio in the CA3 area 
(Kurt et al., 2004; Popov et al., 2011).  Thus, this could cause the observed deficits versus 
controls at the low levels of discrimination (separations 2 and 3).  Another study 
hypothesized that discrimination of distinct stimuli could rely more on mature granule 
cells, rather than immature cells (Nakashiba et al., 2012).  At different stages of 
development, Ts65Dn mice display premature neuronal differentiation (Kurabayashi & 
Sanada, 2013) or an elongation of the G1 phase of the cell cycle (de Lagran et al., 2012).  
Premature neuronal differentiation, as well as a reduction in the number of proliferating 
cells could both eventually lead to a reduction in the number of mature neurons.  (Tejedor 
& Hämmerle, 2011).  While deficits of mature neurons were not examined in the present 
study, they could explain why Ts65Dn mice display deficits on separations 2 and 3. 
Another consideration for impaired Ts65Dn performance on a pattern separation 
task is the overexpression of GABA throughout the hippocampus (Best et al., 2012; 
Kleschevnikov et al., 2012).  A recent study demonstrated that the α5 subunit of GABA-
R in the DG is critical for high discrimination trials in a PS task.  This study also showed 
that the neither the α2 GABA-R subunit in the DG nor the α5 GABA-R subunit in the 
CA1 region was necessary for high discrimination trials, reinforcing that the α5 subunit 
specifically in the DG is necessary for high-demand discrimination trials (Engin et al., 
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2015).  Ts65Dn mice display increases in the number inhibitory interneurons throughout 
the hippocampus (Hernández-González et al., 2015), as well as deficits of DGCs.  
Therefore, I hypothesize that these mice have encoding deficits of similar stimuli, as well 
as deficits in transmitting these representations to the CA3, due to increased inhibition of 
these DGCs.  DS research has shifted towards using inverse agonists in Ts65Dn mice, 
with studies reporting rescued learning and memory deficits (Braudeau et al., 2011).  
Recently, the compound RO4938581 was chronically administered for six weeks to 
Ts65Dn mice and was reported to rescue multiple behavioral and histological deficits 
(Martínez-Cué et al., 2013).  RO4938581 is currently in Phase 2 clinical trials to treat the 
cognitive deficits observed in DS (Rudolph & Möhler, 2013). 
Other studies have found that neurogenesis-deficient animals did poorly on both 
the low and high discrimination trials (Guo et al., 2011; Zhang et al., 2014).  The 
hyperactive nature of Ts65Dn mice (Stringer et al., 2015) could lead to more exploratory 
behavior in the maze, thus decreasing the motivation to choose the correct arm in any of 
the separation trials.  It will be critical to gather more data on the latency measures during 
this task, in order to determine if any motor or motivational effects are seen in the 
Ts65Dn mice. Another factor that should be taken into consideration with these results in 
the variability of performances across animals.  The Ts65Dn mice used in this study were 
maintained on a 50% background of C57BL/6 and C3H mice, which could contribute to 
the wide performance range that is observed.  For instance, C57 and C3 mice have been 
shown to have contrasting performances on a rotarod task (Rogers et al., 1999).  In the 
current task, animals could be trained to a certain criterion to determine if performance 
above chance levels could be achieved.  In this study, all animals as a group averaged 
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above chance percentages; however, the previously mentioned procedural change would 
provide us with a better understanding of the Ts65Dn’s ability or inability to learn a 
pattern separation task.   
 
4.2 The Effect of EGCG on proliferation in the Ts65Dn dentate gyrus of the dorsal 
hippocampus 
There were significant differences in the total number of BrdU-labeled cell 
counts, with euploid animals having higher cell counts versus trisomic mice.  These 
differences were evident without differences in the section thickness, total sampled 
volume, average volume per slice, and density of labeled cells in the DG.  However, 
Furthermore, EGCG does not appear to be significantly change the cell counts.  These 
results agree with previous findings reporting proliferation deficits in the Ts65Dn mouse, 
however the lack of effect of EGCG on proliferation contradicts some previous findings.   
Studies have reported that Ts65Dn mice, two to five months old display 
proliferation and apparent short-term survival deficits (Clark et al., 2006).  In this study, 
BrdU was administered for 9 consecutive days, and the authors examined both cell 
proliferation and short-term survival.  In order to differentiate between these two 
processes, they measured the percentage of cells that appeared in clusters (indicative of 
cell proliferation), whereas those migrating would be counted towards short-term 
survival. Another study used 2-3 month old Ts65Dn mice, and injected BrdU (50mg/kg) 
once a day for 6 consecutive days.  24 hours after the last injection, the mice were 
sacrificed.  They examined the density of BrdU+ cells in the DG, and found that Ts65Dn 
had a significantly lower BrdU+ cell density, however, they did not have any significant 
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BrdU+ cell cluster densities (Belichenko & Kleschevnikov, 2011).  They further 
examined these clusters of BrdU+ cells and found that Ts65Dn mice had a fewer number 
of cells per cluster.  These findings are in agreement with a Ts65Dn proliferation deficit.  
As a field, there are few studies using BrdU to analyze adult Ts65Dn cellular 
proliferation.  However, early formula-based findings suggest that adult Ts65Dn mice 
have decreases in cell counts throughout the hippocampus, and possibly volume deficits 
in the DG (Insausti et al., 1998; Lorenzi & Reeves, 2006).  However, these studies did 
not utilize a cellular marker, such as BrdU, thus these quantitative cellular deficits 
observed in Ts65Dn does not necessarily equate to deficits in cell proliferation or cell 
survival.   
The current study did not find any effects of EGCG on proliferation in the DG, 
although additional subjects need to be added to assure reliability of this conclusion.  
EGCG and its effect on hippocampal neurogenesis have yielded mixed results from 
multiple studies.  One study examined BALB/cJ mice receiving ~250 mg/kg/day of 
EGCG via feeding chow for 39 consecutive days, beginning at eleven weeks of age.  
Also beginning at eleven weeks of age, mice were injected with BrdU (50mg/kg) for 10 
consecutive days then sacrificed 30 days after the last injection.  EGCG did not have any 
effects on the number of surviving BrdU+ cells in the DG (Bhattacharya et al., 2015).  
Another study reported that a single injection of Brdu (50mg/kg), followed by a  four 
week treatment of EGCG (25mg/kg), administered via oral gavage significantly increased 
the number of cells in the DG (Yoo et al., 2010).  Treatment with EGCG increased the 
number of Ki67+ cells in the subgranular zone of the dentate gyrus by 221% compared to 
the vehicle group.  However, these comparisons were made at an unknown age.  Another 
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study examined the effect of a two-month administration of EGCG (20mg/kg) via 
injection, beginning on PD 60, in C57BL/6J mice.  For their cell proliferation study, mice 
were given a single 100mg/kg injection of BrdU after their last EGCG injection, and then 
sacrificed two hours later.  For their cell survival study, four-month old mice were given 
four daily consecutive injections of BrdU, and then were sacrificed four weeks later.  The 
dose of BrdU or if EGCG treatment continued throughout the four weeks was not 
reported.  They reported that a two-month administration of EGCG increased the number 
of BrdU+ cells in the subgranular zone of DG approximately 40%.  EGCG also increased 
the density of BrdU-labeld cells in the granule cell layer of the DG.  However, EGCG did 
not increase the number of BrdU/NeuN co-labeled cells, nor did it increase the number of 
BrdU/DCX co-labeled cells.  Thus, administration of EGCG does not appear to be having 
an effect on the survival of newly generated cells (Wang et al., 2012).   
The previous studies showing the positive effect of EGCG on cell proliferation s 
contradict what was found in the current study.  Two stark differences are the strain of 
mice that was used and the route and dose of EGCG treatment. The studies that used 
C57BL/6J mice found a positive effect of EGCG on proliferation, whereas the BALB/cj 
strain did not report any effects.  The Ts65Dn mice used in this study were maintained on 
a 50% background of C57BL/6 and C3H mice.  To date, there have been no studies 
looking at the effects of EGCG administration on C3H mice or hybrid B6/C3H mice.  
Thus, strain differences could be contributing to the discrepancies in the proliferation 
results.  Interestingly, both studies reporting positive effects of EGCG on cell 
proliferation used forms of EGCG that were very similar to the one used in the current 
study (purchased from Sigma-Aldrich).  One study used systemic injections to administer 
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EGCG, whereas the other used oral gavage to administer EGCG, rather than via drinking 
water, as administered for  approximately eight weeks in the current study .  This is a 
similar administration timeline compared to the two month, 20mg/kg injection of EGCG 
study.  Thus, the route of EGCG administration could be attributing to the lack of effects 
observed.  These differences in administration methodology could be contributing to the 
lack of effect of EGCG observed in this study.   
 
4.3 Conclusions and future directions 
This study demonstrated that Ts65Dn mice display deficits on a spatial pattern 
separation radial arm maze task in both acquisition, as well as on all degrees of difficulty.  
This task has not previously been examined in these mice, and results demonstrate a 
novel cognitive phenotype for the Ts65Dn mice.  EGCG does not alleviate any of the 
deficits that are observed in this task, nor does it increase cell proliferation in these mice.    
The pattern separation task may prove to be valuable for studies of mouse models of DS, 
as prior studies suggest that this task could be a direct correlate to adult hippocampal 
neurogenesis.  Pattern separation tasks are currently being used in a clinical setting, with 
computerized versions of the tasks (Yassa et al., 2011); (Bakker et al., 2008; Stark et al., 
2013).  Thus, the use of a pattern separation task in Ts65Dn mice to evaluate potential 
treatments could improve the external and face validity of any future findings.  
While not directly examined in this study, Dyrk1a could be playing a crucial role 
in the proliferation and subsequent pattern separation deficits in the Ts65Dn mouse.  
Dyrk1a  has been shown to regulate Cyclin D1, a key cell cycle regulator, especially in 
the G1 phase, where signaling either induces differentiation, or more cellular division 
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(Dehay & Kennedy, 2007).  Increases in Dyrk1a  expression has been shown to lengthen 
the G1 phase, possibly causing a delay in neocortical wall growth, and thus producing 
fewer neurons early in development (Chakrabarti et al., 2007; Najas et al., 2015).  Dyrk1a  
has also been shown to result in premature neuronal differentiation (Yabut, Domogauer, 
& D'Arcangelo, 2010).  Together, these studies suggest that Dyrk1a mediates deficits in 
cell proliferation and differentiation.  Furthermore, Ts65Dn mice that express only two 
copies of Dyrk1a display normal performance on memory tasks, as well as normalized 
synaptic plasticity and cell proliferation (Garcia-Cerro et al., 2014).  In order to better 
understand the role of Dyrk1a  in Ts65Dn mice, Ts65Dn mice should be crossed with 
Dyrk1a knockdown mice, resulting in four main groups (Euploid +/+, Euploid +/-, 
Trisomic +/+/+, Trisomic +/+/-). Trisomic (+/+/-) mice will have the normal trisomic 
complement of genes except for Dyrk1a (reduced to two copies), and should illustrate the 
role of Dyrk1a in learning and memory tasks, such as pattern separation. 
These findings implicate Dyrk1a in playing a role in numerous developmental 
processes.  In vitro administration of EGCG, a known Dyrk1a inhibitor (Bain et al., 2003) 
has been shown to restore LTP, rescue proliferation/differentiation deficits, and decrease 
Dyrk1a activity (Hibaoui et al., 2014; Xie et al., 2008).  As previously mentioned, EGCG 
has been found to increase cell proliferation, but did not have an effect in cell survival 
studies, suggesting that this increase in cell production does not translate to mature 
integration of newly generated cells into functional circuits in the hippocampus.  Moving 
forward, it will be important to analyze not only proliferation, but cell survival 
throughout the hippocampus.  EGCG has been reported to show a trend towards reducing 
Dyrk1a activity in the cerebellum of Ts65Dn mice, however, this was not significant 
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(p=0.06) (Stringer et al., 2015).  One factor that could be contributing to this is EGCG’s 
high solubility, which is hypothesized to result in poor membrane permeability (Smith, 
2011).  This could causing the rapid degradation that has been observed (Stringer et al., 
2015).  When mice were injected with either 25mg/kg or 50mg/kg EGCG, and killed 24 
hours later, EGCG levels in the brain were one tenth of the amount that was measured in 
various organs (Smith, 2011).   Thus, while EGCG does cross the blood brain barrier, 
EGCG administered via drinking water (as used in the current study) may not be the best 
route of administration in order to see histological or behavioral changes in the mouse 
brain.  Studies in humans have increased the bioavailability of EGCG by administering it 
with ascorbic acid and omega-3 (Mereles & Hunstein, 2011).  Another study made 
EGCG more hydrophobic via acetylation, and reported increased serum levels and an 
increased half-life of EGCG (Lambert et al., 2006a; Lambert et al., 2006b).  In order to 
deliver a more controlled, higher dose of EGCG, mice should be orally gavaged with 
EGCG every day.  From a pharmacological approach, analysis of EGCG levels in the 
serum of Ts65Dn mice will allow us to understand how much EGCG is getting into the 
blood stream.  However, even more important is to identify how much EGCG is in the 
brain, and to determine if it affects Dyrk1a activity levels.
 
 
 
 
 
 
  
5
0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
49 
 
 
5
0
 
REFERENCES 
Abrous, D. N., Koehl, M., & Le Moal, M. (2005). Adult neurogenesis: from precursors to 
network and physiology. Physiological reviews, 85(2), 523-569.   
Adayev, T., Chen-Hwang, M. C., & Murakami, N. (2006). Kinetic properties of a 
MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. 
Biochemistry.   
Ahmad, N., Feyes, D. K., Agarwal, R., Mukhtar, H., & Nieminen, A.-L. (1997). Green 
tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell 
cycle arrest in human carcinoma cells. Journal of the National Cancer Institute, 
89(24), 1881-1886.  
Aimone, J. B., Li, Y., Lee, S. W., Clemenson, G. D., Deng, W., & Gage, F. H. (2014). 
Regulation and function of adult neurogenesis: from genes to cognition. 
Physiological reviews, 94(4), 991-1026.  
Altafaj, X., Dierssen, M., Baamonde, C., Martí, E., Visa, J., Guimerà, J., . . . Estivill, X. 
(2001). Neurodevelopmental delay, motor abnormalities and cognitive deficits in 
transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's 
syndrome. Hum Mol Genet, 10(18), 1915-1923.   
Altafaj, X., Martín, E. D., & Ortiz-Abalia, J. (2013). Normalization of Dyrk1A 
expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in 
the Ts65Dn mouse model of Down syndrome. Neurobiology of ….   
Altman, J. (1969). Autoradiographic and histological studies of postnatal neurogenesis. 
IV. Cell proliferation and migration in the anterior forebrain, with special 
reference to persisting neurogenesis in the olfactory bulb. Journal of Comparative 
Neurology, 137(4), 433-457.  
Altman, J., Brunner, R. L., & Bayer, S. A. (1973). The hippocampus and behavioral 
maturation. Behav Biol, 8(5), 557-596.   
Altman, J., & Das, G. D. (1965). Autoradiographic and histological evidence of postnatal 
hippocampal neurogenesis in rats. J Comp Neurol, 124(3), 319-335.   
Alvarez-Buylla, A., & Lim, D. A. (2004). For the long run: maintaining germinal niches 
in the adult brain. Neuron, 41(5), 683-686.  
Amaral, D., & Witter, M. (1989). The three-dimensional organization of the hippocampal 
formation: a review of anatomical data. Neuroscience, 31(3), 571-591.  
Amaral, D. G., Ishizuka, N., & Claiborne, B. (1990). Chapter Neurons, numbers and the 
hippocampal network. Progress in brain research, 83, 1-11.
50 
 
 
5
0
 
Amaral, D. G., Scharfman, H. E., & Lavenex, P. (2007). The dentate gyrus: fundamental 
neuroanatomical organization (dentate gyrus for dummies). Progress in brain 
research, 163, 3-790.  
Aylward, E. H., Li, Q., Habbak, Q. R., Warren, A., Pulsifer, M. B., Barta, P. E., . . . 
Pearlson, G. (1997). Basal ganglia volume in adults with Down syndrome. 
Psychiatry research, 74(2), 73-82.   
Aylward, E. H., Li, Q., Honeycutt, N. A., Warren, A. C., Pulsifer, M. B., Barta, P. E., . . . 
Pearlson, G. D. (1999). MRI volumes of the hippocampus and amygdala in adults 
with Down's syndrome with and without dementia. The American journal of 
psychiatry, 156(4), 564-568.   
Bain, J., McLauchlan, H., Elliott, M., & Cohen, P. (2003). The specificities of protein 
kinase inhibitors: an update. Biochem. J, 371, 199-204.  
Bakker, A., Kirwan, C. B., Miller, M., & Stark, C. E. (2008). Pattern separation in the 
human hippocampal CA3 and dentate gyrus. Science, 319(5870), 1640-1642.  
Barnes, C. A., McNaughton, B. L., Mizumori, S. J., Leonard, B. W., & Lin, L.-H. (1990). 
Chapter Comparison of spatial and temporal characteristics of neuronal activity in 
sequential stages of hippocampal processing. Progress in brain research, 83, 287-
300.  
Baxter, L. L., Moran, T. H., Richtsmeier, J. T., Troncoso, J., & Reeves, R. H. (2000). 
Discovery and genetic localization of Down syndrome cerebellar phenotypes 
using the Ts65Dn mouse. Hum Mol Genet, 9(2), 195-202.  
Bayer, S. A., & Altman, J. (1974). Hippocampal development in the rat: cytogenesis and 
morphogenesis examined with autoradiography and low-level X-irradiation. J 
Comp Neurol, 158(1), 55-79. doi:10.1002/cne.901580105 
Becker, L. E., Armstrong, D. L., & Chan, F. (1986). Dendritic atrophy in children with 
Down's syndrome. Annals of neurology, 20(4), 520-526. 
doi:10.1002/ana.410200413 
Becker, W., & Joost, H. G. (1999). Structural and functional characteristics of Dyrk, a 
novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res 
Mol Biol, 62, 1-17.   
Becker, W., & Sippl, W. (2011). Activation, regulation, and inhibition of DYRK1A. The 
FEBS journal, 278(2), 246-256. doi:10.1111/j.1742-4658.2010.07956.x 
Begenisic, T., Baroncelli, L., Sansevero, G., Milanese, M., Bonifacino, T., Bonanno, G., . 
. . Sale, A. (2014). Fluoxetine in adulthood normalizes GABA release and rescues 
hippocampal synaptic plasticity and spatial memory in a mouse model of Down 
syndrome. Neurobiol Dis, 63, 12-19. doi:10.1016/j.nbd.2013.11.010 
Belichenko, P. V., & Kleschevnikov, A. M. (2011). Deficiency of adult neurogenesis in 
the Ts65Dn mouse model of Down syndrome: INTECH Open Access Publisher. 
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, 
A., & Mobley, W. C. (2004). Synaptic structural abnormalities in the Ts65Dn 
mouse model of Down Syndrome. Journal of Comparative Neurology, 480(3), 
281-298.  
 
 
51 
 
 
5
1
 
Benavides-Piccione, R., Ballesteros-Yanez, I., de Lagran, M. M., Elston, G., Estivill, X., 
Fillat, C., . . . Dierssen, M. (2004). On dendrites in Down syndrome and DS 
murine models: a spiny way to learn. Prog Neurobiol, 74(2), 111-126. 
doi:10.1016/j.pneurobio.2004.08.001 
Best, T. K., Cramer, N. P., Chakrabarti, L., Haydar, T. F., & Galdzicki, Z. (2012). 
Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down 
syndrome. Experimental neurology, 233(2), 749-757.  
Bhattacharya, T. K., Pence, B. D., Ossyra, J. M., Gibbons, T. E., Perez, S., McCusker, R. 
H., . . . Rhodes, J. S. (2015). Exercise but not (–)-epigallocatechin-3-gallate or β-
alanine enhances physical fitness, brain plasticity, and behavioral performance in 
mice. Physiology & behavior, 145, 29-37.  
Bianchi, P., Ciani, E., Contestabile, A., Guidi, S., & Bartesaghi, R. (2010a). Lithium 
restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model 
for Down syndrome. Brain Pathology, 20(1), 106-118.  
Bianchi, P., Ciani, E., & Guidi, S. (2010b). Early pharmacotherapy restores neurogenesis 
and cognitive performance in the Ts65Dn mouse model for Down syndrome. The 
Journal of ….   
Bianchi, P., Ciani, E., Guidi, S., Trazzi, S., Felice, D., Grossi, G., . . . Bartesaghi, R. 
(2010c). Early pharmacotherapy restores neurogenesis and cognitive performance 
in the Ts65Dn mouse model for Down syndrome. The Journal of neuroscience : 
the official journal of the Society for Neuroscience, 30(26), 8769-8779. 
doi:10.1523/JNEUROSCI.0534-10.2010 
Blazek, J. D., Malik, A. M., Tischbein, M., Arbones, M. L., Moore, C. S., & Roper, R. J. 
(2015). Abnormal mineralization of the Ts65Dn Down syndrome mouse 
appendicular skeleton begins during embryonic development in a Dyrk1a-
independent manner. Mech Dev, 136, 133-142. doi:10.1016/j.mod.2014.12.004 
Bon, B. W. M. V., & Hoischen, A. (2011). Intragenic deletion in DYRK1A leads to 
mental retardation and primary microcephaly. Clinical ….   
Braudeau, J., Delatour, B., Duchon, A., Pereira, P. L., Dauphinot, L., de Chaumont, F., . . 
. Potier, M.-C. (2011). Specific targeting of the GABA-A receptor α5 subtype by 
a selective inverse agonist restores cognitive deficits in Down syndrome mice. 
Journal of Psychopharmacology, 25(8), 1030-1042.  
Broadbent, N. J., Squire, L. R., & Clark, R. E. (2004). Spatial memory, recognition 
memory, and the hippocampus. Proc Natl Acad Sci U S A, 101(40), 14515-14520.  
Brown, J. P., Couillard‐Després, S., Cooper‐Kuhn, C. M., Winkler, J., Aigner, L., & 
Kuhn, H. G. (2003). Transient expression of doublecortin during adult 
neurogenesis. Journal of Comparative Neurology, 467(1), 1-10.  
Brun, V. H., Otnæss, M. K., Molden, S., Steffenach, H.-A., Witter, M. P., Moser, M.-B., 
& Moser, E. I. (2002). Place cells and place recognition maintained by direct 
entorhinal-hippocampal circuitry. Science, 296(5576), 2243-2246.  
Bull, M. J. (2011). Health supervision for children with Down syndrome. Pediatrics, 
128(2), 393-406. doi:10.1542/peds.2011-1605 
Burke, S. N., Wallace, J. L., Hartzell, A. L., Nematollahi, S., Plange, K., & Barnes, C. A. 
(2011). Age-associated deficits in pattern separation functions of the perirhinal 
cortex: a cross-species consensus. Behavioral neuroscience, 125(6), 836.  
52 
 
 
5
2
 
Cameron, H. A., & Mckay, R. D. (2001). Adult neurogenesis produces a large pool of 
new granule cells in the dentate gyrus. Journal of Comparative Neurology, 
435(4), 406-417.  
Cameron, H. A., Woolley, C. S., McEwen, B. S., & Gould, E. (1993). Differentiation of 
newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience, 
56(2), 337-344.  
Carlesimo, G. A., Marotta, L., & Vicari, S. (1997). Long-term memory in mental 
retardation: evidence for a specific impairment in subjects with Down's syndrome. 
Neuropsychologia, 35(1), 71-79.   
Center, J., Beange, H., & McElduff, A. (1998). People with mental retardation have an 
increased prevalence of osteoporosis: a population study. American Journal on 
Mental Retardation, 103(1), 19-28.  
Chakrabarti, L., Best, T. K., Cramer, N. P., Carney, R. S. E., Isaac, J. T. R., Galdzicki, Z., 
& Haydar, T. F. (2010). Olig1 and Olig2 triplication causes developmental brain 
defects in Down syndrome. Nature neuroscience, 13(8), 927-934. 
doi:10.1038/nn.2600 
Chakrabarti, L., Galdzicki, Z., & Haydar, T. F. (2007). Defects in embryonic 
neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse 
model of Down syndrome. The Journal of neuroscience, 27(43), 11483-11495.  
Chapman, R. S., & Hesketh, L. J. (2000). Behavioral phenotype of individuals with 
Down syndrome. Mental retardation and developmental disabilities research 
reviews, 6(2), 84-95. doi:10.1002/1098-2779(2000)6:2<84::AID-
MRDD2>3.0.CO;2-P 
Chen, B. Y., Wang, X., Wang, Z. Y., Wang, Y. Z., Chen, L. W., & Luo, Z. J. (2013). 
Brain‐derived neurotrophic factor stimulates proliferation and differentiation of 
neural stem cells, possibly by triggering the Wnt/β‐catenin signaling pathway. J 
Neurosci Res, 91(1), 30-41.  
Choi, J.-Y., Park, C.-S., Kim, D.-J., Cho, M.-H., Jin, B.-K., Pie, J.-E., & Chung, W.-G. 
(2002). Prevention of Nitric Oxide-Mediated 1-Methyl-4-Phenyl-1,2,3,6-
Tetrahydropyridine-Induced Parkinson’s Disease in Mice by Tea Phenolic 
Epigallocatechin 3-Gallate. Neurotoxicology, 23(3), 367-374. doi:10.1016/S0161-
813X(02)00079-7 
Clelland, C., Choi, M., Romberg, C., Clemenson, G., Fragniere, A., Tyers, P., . . . Gage, 
F. (2009a). A functional role for adult hippocampal neurogenesis in spatial pattern 
separation. Science, 325(5937), 210-213.  
Clelland, C. D., Choi, M., Romberg, C., Clemenson, G. D., Jr., Fragniere, A., Tyers, P., . 
. . Bussey, T. J. (2009b). A functional role for adult hippocampal neurogenesis in 
spatial pattern separation. Science, 325(5937), 210-213. 
doi:10.1126/science.1173215 
Contestabile, A., Fila, T., Cappellini, A., Bartesaghi, R., & Ciani, E. (2009). Widespread 
impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down 
syndrome. Cell proliferation, 42(2), 171-181. doi:10.1111/j.1365-
2184.2009.00587.x 
 
53 
 
 
5
3
 
Contestabile, A., Fila, T., Ceccarelli, C., Bonasoni, P., Bonapace, L., Santini, D., . . . 
Ciani, E. (2007). Cell cycle alteration and decreased cell proliferation in the 
hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with 
Down syndrome and in Ts65Dn mice. Hippocampus, 17(8), 665-678.  
Contestabile, A., Greco, B., Ghezzi, D., Tucci, V., Benfenati, F., & Gasparini, L. (2012). 
Lithium rescues synaptic plasticity and memory in Down syndrome mice. Journal 
of Clinical Investigation, 123(1), 348-361. doi:10.1172/JCI64650 
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, 
J., . . . Mobley, W. C. (2001). Failed retrograde transport of NGF in a mouse 
model of Down's syndrome: reversal of cholinergic neurodegenerative 
phenotypes following NGF infusion. Proceedings of the National Academy of 
Sciences, 98(18), 10439-10444.  
Costa, A. C., Stasko, M. R., Schmidt, C., & Davisson, M. T. (2010). Behavioral 
validation of the Ts65Dn mouse model for Down syndrome of a genetic 
background free of the retinal degeneration mutation Pde6b rd1. Behavioural 
brain research, 206(1), 52-62.  
Costa, A. C. S., Scott-McKean, J. J., & Stasko, M. R. (2008). Acute injections of the 
NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn 
mouse model of Down syndrome on a fear conditioning test. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology, 33(7), 1624-1632. doi:10.1038/sj.npp.1301535 
Courcet, J.-B., Faivre, L., Malzac, P., Masurel-Paulet, A., Lopez, E., Callier, P., . . . 
Thauvin-Robinet, C. (2012). The DYRK1A gene is a cause of syndromic 
intellectual disability with severe microcephaly and epilepsy. Journal of medical 
genetics, 49(12), 731-736. doi:10.1136/jmedgenet-2012-101251 
Creer, D. J., Romberg, C., Saksida, L. M., van Praag, H., & Bussey, T. J. (2010). 
Running enhances spatial pattern separation in mice. Proceedings of the National 
Academy of Sciences, 107(5), 2367-2372.  
Cushman, J. D., Maldonado, J., Kwon, E. E., Garcia, A. D., Fan, G., Imura, T., . . . 
Fanselow, M. S. (2012). Juvenile neurogenesis makes essential contributions to 
adult brain structure and plays a sex-dependent role in fear memories. Frontiers in 
behavioral neuroscience, 6.  
Dayer, A. G., Ford, A. A., Cleaver, K. M., Yassaee, M., & Cameron, H. A. (2003). Short‐
term and long‐term survival of new neurons in the rat dentate gyrus. Journal of 
Comparative Neurology, 460(4), 563-572.  
De la Torre, R., De Sola, S., Pons, M., Duchon, A., de Lagran, M. M., Farre, M., . . . 
Dierssen, M. (2014). Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues 
cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr 
Food Res, 58(2), 278-288. doi:10.1002/mnfr.201300325 
de Lagran, M. M., Benavides-Piccione, R., Ballesteros-Yañez, I., Calvo, M., Morales, 
M., Fillat, C., . . . Dierssen, M. (2012). Dyrk1A influences neuronal 
morphogenesis through regulation of cytoskeletal dynamics in mammalian 
cortical neurons. Cerebral Cortex, bhr362.  
 
54 
 
 
5
4
 
Dehay, C., & Kennedy, H. (2007). Cell-cycle control and cortical development. Nature 
Reviews Neuroscience, 8(6), 438-450.  
Demas, G. E., Nelson, R. J., Krueger, B. K., & Yarowsky, P. J. (1996). Spatial memory 
deficits in segmental trisomic Ts65Dn mice. Behavioural brain research, 82(1), 
85-92.  
Demas, G. E., Nelson, R. J., Krueger, B. K., & Yarowsky, P. J. (1998). Impaired spatial 
working and reference memory in segmental trisomy (Ts65Dn) mice. Behavioural 
brain research, 90(2), 199-201.  
Deshmukh, S. S., & Knierim, J. J. (2011). Representation of non-spatial and spatial 
information in the lateral entorhinal cortex. Frontiers in behavioral neuroscience, 
5.  
Dong, Z., Ma, W.-y., Huang, C., & Yang, C. S. (1997). Inhibition of tumor promoter-
induced activator protein 1 activation and cell transformation by tea 
polyphenols,(-)-epigallocatechin gallate, and theaflavins. Cancer research, 
57(19), 4414-4419.  
Dowjat, W. K., Adayev, T., Kuchna, I., Nowicki, K., Palminiello, S., Hwang, Y. W., & 
Wegiel, J. (2007). Trisomy-driven overexpression of DYRK1A kinase in the 
brain of subjects with Down syndrome. Neuroscience letters, 413(1), 77-81.  
Dragoi, G., Carpi, D., Recce, M., Csicsvari, J., & Buzsáki, G. (1999). Interactions 
between hippocampus and medial septum during sharp waves and theta 
oscillation in the behaving rat. The Journal of neuroscience, 19(14), 6191-6199.  
Duan, X., Chang, J. H., Ge, S., Faulkner, R. L., Kim, J. Y., Kitabatake, Y., . . . Ma, D. K. 
(2007). Disrupted-In-Schizophrenia 1 regulates integration of newly generated 
neurons in the adult brain. Cell, 130(6), 1146-1158.  
Dupret, D., Montaron, M. F., Drapeau, E., Aurousseau, C., Le Moal, M., Piazza, P. V., & 
Abrous, D. N. (2005). Methylazoxymethanol acetate does not fully block cell 
genesis in the young and aged dentate gyrus. European Journal of Neuroscience, 
22(3), 778-783.  
Eichenbaum, H., Stewart, C., & Morris, R. (1990). Hippocampal representation in place 
learning. The Journal of neuroscience, 10(11), 3531-3542.  
Engin, E., Zarnowska, E. D., Benke, D., Tsvetkov, E., Sigal, M., Keist, R., . . . Rudolph, 
U. (2015). Tonic Inhibitory Control of Dentate Gyrus Granule Cells by α5-
Containing GABAA Receptors Reduces Memory Interference. The Journal of 
neuroscience, 35(40), 13698-13712.  
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, 
D. A., & Gage, F. H. (1998). Neurogenesis in the adult human hippocampus. 
Nature medicine, 4(11), 1313-1317.  
Escorihuela, R. M., Fernandez-Teruel, A., Vallina, I. F., Baamonde, C., Lumbreras, M. 
A., Dierssen, M., . . . Florez, J. (1995). A behavioral assessment of Ts65Dn mice: 
a putative Down syndrome model. Neurosci Lett, 199(2), 143-146.  
Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & 
Garner, C. C. (2007). Pharmacotherapy for cognitive impairment in a mouse 
model of Down syndrome. Nat Neurosci, 10(4), 411-413. doi:10.1038/nn1860 
55 
 
 
5
5
 
Fotaki, V., & Dierssen, M. (2002). Dyrk1A haploinsufficiency affects viability and 
causes developmental delay and abnormal brain morphology in mice. … and 
Cellular Biology.  
Frankiewicz, T., & Parsons, C. G. (1999). Memantine restores long term potentiation 
impaired by tonic N-methyl-d-aspartate (NMDA) receptor activation following 
reduction of Mg 2+ in hippocampal slices. Neuropharmacology, 38(9), 1253-
1259.  
Freeman, S. B., Bean, L. H., Allen, E. G., Tinker, S. W., Locke, A. E., Druschel, C., . . . 
Sherman, S. L. (2008). Ethnicity, sex, and the incidence of congenital heart 
defects: a report from the National Down Syndrome Project. Genetics in medicine 
: official journal of the American College of Medical Genetics, 10(3), 173-180. 
doi:10.1097/GIM.0b013e3181634867 
Freeman, S. B., Taft, L. F., Dooley, K. J., Allran, K., Sherman, S. L., Hassold, T. J., . . . 
Saker, D. M. (1998). Population-based study of congenital heart defects in Down 
syndrome. American Journal of Medical Genetics, 80(3), 213-217.   
Frenkel, S., & Bourdin, B. (2009). Verbal, visual, and spatio-sequential short-term 
memory: assessment of the storage capacities of children and teenagers with 
Down's syndrome. Journal of intellectual disability research : JIDR, 53(2), 152-
160. doi:10.1111/j.1365-2788.2008.01139.x 
Frotscher, M., & Zimmer, J. (1983). Commissural fibers terminate on non-pyramidal 
neurons in the guinea pig hippocampus—a combined Golgi/EM degeneration 
study. Brain Research, 265(2), 289-293.  
Gage, F. H., & Temple, S. (2013). Neural stem cells: generating and regenerating the 
brain. Neuron, 80(3), 588-601.  
Garcia-Cerro, S., Martinez, P., Vidal, V., Corrales, A., Florez, J., Vidal, R., . . . Martinez-
Cue, C. (2014). Overexpression of Dyrk1A is implicated in several cognitive, 
electrophysiological and neuromorphological alterations found in a mouse model 
of Down syndrome. PLoS One, 9(9), e106572. doi:10.1371/journal.pone.0106572 
Garcia, A. D. R., Doan, N. B., Imura, T., Bush, T. G., & Sofroniew, M. V. (2004). 
GFAP-expressing progenitors are the principal source of constitutive 
neurogenesis in adult mouse forebrain. Nature neuroscience, 7(11), 1233-1241.  
Gardiner, K. J. (2010). Molecular basis of pharmacotherapies for cognition in Down 
syndrome. Trends in pharmacological sciences, 31(2), 66-73.  
Ge, S., Goh, E. L., Sailor, K. A., Kitabatake, Y., Ming, G.-l., & Song, H. (2006). GABA 
regulates synaptic integration of newly generated neurons in the adult brain. 
Nature, 439(7076), 589-593.  
Ge, S., Pradhan, D. A., Ming, G.-l., & Song, H. (2007). GABA sets the tempo for 
activity-dependent adult neurogenesis. Trends in neurosciences, 30(1), 1-8.  
Goodrich‐Hunsaker, N. J., Livingstone, S. A., Skelton, R. W., & Hopkins, R. O. (2010). 
Spatial deficits in a virtual water maze in amnesic participants with hippocampal 
damage. Hippocampus, 20(4), 481-491.  
Gould, E., Beylin, A., Tanapat, P., Reeves, A., & Shors, T. J. (1999). Learning enhances 
adult neurogenesis in the hippocampal formation. Nature neuroscience, 2(3), 260-
265.  
56 
 
 
5
6
 
Gratzner, H. G. (1982). Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A 
new reagent for detection of DNA replication. Science, 218(4571), 474-475.   
Groves, J. O., Leslie, I., Huang, G.-J., McHugh, S. B., Taylor, A., Mott, R., . . . Flint, J. 
(2013). Ablating adult neurogenesis in the rat has no effect on spatial processing: 
evidence from a novel pharmacogenetic model. PLoS Genet, 9(9), e1003718-
e1003718.  
Guedj, F., Sébrié, C., Rivals, I., Ledru, A., & Paly, E. (2009). Green tea polyphenols 
rescue of brain defects induced by overexpression of DYRK1A. PLoS One.   
Guidi, S., Bonasoni, P., Ceccarelli, C., Santini, D., Gualtieri, F., Ciani, E., & Bartesaghi, 
R. (2008). Neurogenesis impairment and increased cell death reduce total neuron 
number in the hippocampal region of fetuses with Down syndrome. Brain 
Pathology, 18(2), 180-197.  
Guijarro, M., Valero, C., Paule, B., Gonzalez‐Macias, J., & Riancho, J. (2008). Bone 
mass in young adults with Down syndrome. Journal of Intellectual Disability 
Research, 52(3), 182-189.  
Guo, W., Allan, A. M., Zong, R., Zhang, L., Johnson, E. B., Schaller, E. G., . . . Oostra, 
B. A. (2011). Ablation of Fmrp in adult neural stem cells disrupts hippocampus-
dependent learning. Nature medicine, 17(5), 559-565.  
Hack, M. A., Saghatelyan, A., De Chevigny, A., Pfeifer, A., Ashery-Padan, R., Lledo, P.-
M., & Götz, M. (2005). Neuronal fate determinants of adult olfactory bulb 
neurogenesis. Nature neuroscience, 8(7), 865-872.  
Hafting, T., Fyhn, M., Molden, S., Moser, M.-B., & Moser, E. I. (2005). Microstructure 
of a spatial map in the entorhinal cortex. Nature, 436(7052), 801-806.  
Hernández-González, S., Ballestín, R., López-Hidalgo, R., Gilabert-Juan, J., Blasco-
Ibáñez, J. M., Crespo, C., . . . Varea, E. (2015). Altered Distribution of 
Hippocampal Interneurons in the Murine Down Syndrome Model Ts65Dn. 
Neurochemical research, 40(1), 151-164.  
Hernandez-Rabaza, V., Llorens-Martin, M., Velazquez-Sanchez, C., Ferragud, A., 
Arcusa, A., Gumus, H., . . . Trejo, J. L. (2009). Inhibition of adult hippocampal 
neurogenesis disrupts contextual learning but spares spatial working memory, 
long-term conditional rule retention and spatial reversal. Neuroscience, 159(1), 
59-68.  
Hibaoui, Y., Grad, I., Letourneau, A., Sailani, M. R., Dahoun, S., Santoni, F. A., . . . Feki, 
A. (2014). Modelling and rescuing neurodevelopmental defect of Down syndrome 
using induced pluripotent stem cells from monozygotic twins discordant for 
trisomy 21. EMBO Mol Med, 6(2), 259-277. doi:10.1002/emmm.201302848 
Hodge, R. D., Kowalczyk, T. D., Wolf, S. A., Encinas, J. M., Rippey, C., Enikolopov, G., 
. . . Hevner, R. F. (2008). Intermediate progenitors in adult hippocampal 
neurogenesis: Tbr2 expression and coordinate regulation of neuronal output. The 
Journal of neuroscience, 28(14), 3707-3717.  
Howard-Jones, N. (1979). On the diagnostic term “Down's disease”. Medical History, 
23(01), 102-104.  
Hyde, L. A., Frisone, D. F., & Crnic, L. S. (2001). Ts65Dn mice, a model for Down 
syndrome, have deficits in context discrimination learning suggesting impaired 
hippocampal function. Behav Brain Res, 118(1), 53-60.  
57 
 
 
5
7
 
Insausti, A. M., Megías, M., Crespo, D., Cruz-Orive, L. M., Dierssen, M., Vallina, I. F., . 
. . Vallina, T. F. (1998). Hippocampal volume and neuronal number in Ts65Dn 
mice: a murine model of Down syndrome. Neuroscience letters, 253(3), 175-178.   
Jarrold, C., & Baddeley, A. D. (1997). Short-term Memory for Verbal and Visuospatial 
Information in Down's Syndrome. Cogn Neuropsychiatry, 2(2), 101-122. 
doi:10.1080/135468097396351 
Jarrold, C., Baddeley, A. D., & Phillips, C. E. (2002). Verbal short-term memory in 
Down syndrome: a problem of memory, audition, or speech? Journal of speech, 
language, and hearing research : JSLHR, 45(3), 531-544.   
Jernigan, T. L., Bellugi, U., Sowell, E., Doherty, S., & Hesselink, J. R. (1993). Cerebral 
Morphologic Distinctions Between Williams and Down Syndromes. Archives of 
Neurology, 50(2), 186-191. doi:10.1001/archneur.1993.00540020062019 
Johnston, M. V., & Coyle, J. T. (1979). Histological and neurochemical effects of fetal 
treatment with methylazoxymethanol on rat neocortex in adulthood. Brain 
Research, 170(1), 135-155.  
Josey, M., & Brigman, J. L. (2015). Loss of hippocampal function impairs pattern 
separation on a mouse touch-screen operant paradigm. Neurobiology of learning 
and memory, 125, 85-92.  
Källén, B., Mastroiacovo, P., & Robert, E. (1996). Major congenital malformations in 
Down syndrome. American Journal of Medical Genetics, 65(2), 160-166. 
doi:10.1002/(SICI)1096-8628(19961016)65:2<160::AID-AJMG16>3.0.CO;2-O 
Kaplan, M. S., & Bell, D. H. (1984). Mitotic neuroblasts in the 9-day-old and 11-month-
old rodent hippocampus. The Journal of neuroscience, 4(6), 1429-1441.  
Kaplan, M. S., & Hinds, J. W. (1977). Neurogenesis in the adult rat: electron microscopic 
analysis of light radioautographs. Science, 197(4308), 1092-1094.  
Kee, N., Teixeira, C. M., Wang, A. H., & Frankland, P. W. (2007). Preferential 
incorporation of adult-generated granule cells into spatial memory networks in the 
dentate gyrus. Nature neuroscience, 10(3), 355-362.  
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1997). More hippocampal neurons in 
adult mice living in an enriched environment. Nature, 386(6624), 493-495.  
Kesner, R. P., Hui, X., Sommer, T., Wright, C., Barrera, V. R., & Fanselow, M. S. 
(2014). The role of postnatal neurogenesis in supporting remote memory and 
spatial metric processing. Hippocampus, 24(12), 1663-1671.  
Kesslak, J. P., Nagata, S. F., Lott, I., & Nalcioglu, O. (1994). Magnetic resonance 
imaging analysis of age-related changes in the brains of individuals with Down's 
syndrome. Neurology, 44(6), 1039-1045.   
Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006). Targeting multiple 
signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate. 
Cancer research, 66(5), 2500-2505.  
Kheirbek, M. A., Klemenhagen, K. C., Sahay, A., & Hen, R. (2012). Neurogenesis and 
generalization: a new approach to stratify and treat anxiety disorders. Nature 
neuroscience, 15(12), 1613-1620.  
 
 
58 
 
 
5
8
 
Kleschevnikov, A. M., Belichenko, P. V., Faizi, M., Jacobs, L. F., Htun, K., Shamloo, 
M., & Mobley, W. C. (2012). Deficits in cognition and synaptic plasticity in a 
mouse model of Down syndrome ameliorated by GABAB receptor antagonists. 
The Journal of neuroscience, 32(27), 9217-9227.  
Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & 
Mobley, W. C. (2004). Hippocampal long-term potentiation suppressed by 
increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. 
The Journal of neuroscience, 24(37), 8153-8160.  
Koehler, S., Black, S., Sinden, M., Kidron, D., Szekely, C., Parker, J., . . . Szalai, J. 
(1998). Memory impairments in relation to hippocampal and parahippocampal 
atrophy in Alzheimer’s disease: An MR volumetry study. Neuropsychologia, 36, 
101-114.  
Kostoff, R. N., Briggs, M. B., & Lyons, T. J. (2008). Literature-related discovery (LRD): 
Potential treatments for Multiple Sclerosis. Technological Forecasting and Social 
Change, 75(2), 239-255. doi:10.1016/j.techfore.2007.11.002 
Kronenberg, G., Reuter, K., Steiner, B., Brandt, M. D., Jessberger, S., Yamaguchi, M., & 
Kempermann, G. (2003). Subpopulations of proliferating cells of the adult 
hippocampus respond differently to physiologic neurogenic stimuli. Journal of 
Comparative Neurology, 467(4), 455-463.  
Kurabayashi, N., & Sanada, K. (2013). Increased dosage of DYRK1A and DSCR1 delays 
neuronal differentiation in neocortical progenitor cells. Genes & development, 
27(24), 2708-2721.  
Kurt, M. A., Kafa, M. I., Dierssen, M., & Davies, D. C. (2004). Deficits of neuronal 
density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a 
mouse model of Down syndrome. Brain Research, 1022(1), 101-109.  
Lambert, J. D., Sang, S., Hong, J., Kwon, S.-J., Lee, M.-J., Ho, C.-T., & Yang, C. S. 
(2006a). Peracetylation as a means of enhancing in vitro bioactivity and 
bioavailability of epigallocatechin-3-gallate. Drug metabolism and disposition, 
34(12), 2111-2116.  
Lambert, J. D., Sang, S., Hong, J., Lee, M.-J., Diamond, L., Ju, J., . . . Yang, C. S. 
(2006b). Bioavailability of the green tea polyphenol,(-)-epigallocatechin-3-gallate 
(EGCG), in mice: dose-dependence and improvement via peracetylation. Cancer 
research, 66(8 Supplement), 730-730.  
Lanfranchi, S., Carretti, B., Spanò, G., & Cornoldi, C. (2009). A specific deficit in 
visuospatial simultaneous working memory in Down syndrome. Journal of 
intellectual disability research : JIDR, 53(5), 474-483.  
Lanfranchi, S., Cornoldi, C., & Vianello, R. (2004). Verbal and visuospatial working 
memory deficits in children with Down syndrome. American journal of mental 
retardation : AJMR, 109(6), 456-466. doi:10.1352/0895-
8017(2004)109<456:VAVWMD>2.0.CO;2 
Lavenex, P. B., Bostelmann, M., Brandner, C., Costanzo, F., Fragnière, E., Klencklen, 
G., . . . Vicari, S. (2015). Allocentric spatial learning and memory deficits in 
Down syndrome. Front Psychol, 6, 62-62. doi:10.3389/fpsyg.2015.00062 
59 
 
 
5
9
 
Laws, G. (2002). Working memory in children and adolescents with Down syndrome: 
evidence from a colour memory experiment. J Child Psychol Psychiatry, 43(3), 
353-364.  
Lejeune, J., Gautier, M., & Turpin, R. (1959). Study of somatic chromosomes from 9 
mongoloid children. Comptes rendus hebdomadaires des seances de l'Academie 
des sciences, 248(11), 1721.  
Leverenz, J. B., & Raskind, M. A. (1998). Early amyloid deposition in the medial 
temporal lobe of young Down syndrome patients: a regional quantitative analysis. 
Experimental neurology, 150(2), 296-304.  
Lie, D.-C., Colamarino, S. A., Song, H.-J., Désiré, L., Mira, H., Consiglio, A., . . . Dearie, 
A. R. (2005). Wnt signalling regulates adult hippocampal neurogenesis. Nature, 
437(7063), 1370-1375.  
Llorens-Martin, M. V., Rueda, N., Tejeda, G. S., Florez, J., Trejo, J. L., & Martinez-Cue, 
C. (2010). Effects of voluntary physical exercise on adult hippocampal 
neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome. 
Neuroscience, 171(4), 1228-1240. doi:10.1016/j.neuroscience.2010.09.043 
Lois, C., Garcia-Verdugo, J.-M., & Alvarez-Buylla, A. (1996). Chain migration of 
neuronal precursors. Science, 271(5251), 978-981.  
Lorenzi, H. A., & Reeves, R. H. (2006). Hippocampal hypocellularity in the Ts65Dn 
mouse originates early in development. Brain Research, 1104(1), 153-159.  
Madsen, T. M., Newton, S. S., Eaton, M. E., Russell, D. S., & Duman, R. S. (2003). 
Chronic electroconvulsive seizure up-regulates β-catenin expression in rat 
hippocampus: role in adult neurogenesis. Biological psychiatry, 54(10), 1006-
1014.  
Maeda-Yamamoto, M., Inagaki, N., Kitaura, J., Chikumoto, T., Kawahara, H., 
Kawakami, Y., . . . Nagai, H. (2004). O-methylated catechins from tea leaves 
inhibit multiple protein kinases in mast cells. The Journal of Immunology, 172(7), 
4486-4492.  
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant 
treatment increases neurogenesis in adult rat hippocampus. The Journal of 
neuroscience, 20(24), 9104-9110.  
Marcus, C. L., Keens, T. G., Bautista, D. B., von Pechmann, W. S., & Ward, S. L. 
(1991). Obstructive sleep apnea in children with Down syndrome. Pediatrics, 
88(1), 132-139.  
Marin-Padilla, M. (1976). Pyramidal cell abnormalities in the motor cortex of a child 
with Down's syndrome. A Golgi study. The Journal of comparative neurology, 
167(1), 63-81. doi:10.1002/cne.901670105 
Martí, E., Altafaj, X., Dierssen, M., de la Luna, S., Fotaki, V., Alvarez, M., . . . Estivill, 
X. (2003). Dyrk1A expression pattern supports specific roles of this kinase in the 
adult central nervous system. Brain Research, 964(2), 250-263.  
Martínez-Cué, C., Martínez, P., Rueda, N., Vidal, R., García, S., Vidal, V., . . . Flórez, J. 
(2013). Reducing GABAA α5 receptor-mediated inhibition rescues functional and 
neuromorphological deficits in a mouse model of down syndrome. The Journal of 
neuroscience, 33(9), 3953-3966.  
60 
 
 
6
0
 
Martınez de Lagrán, M., Altafaj, X., Gallego, X., Martı, E., Estivill, X., Sahun, I., . . . 
Dierssen, M. (2004). Motor phenotypic alterations in TgDyrk1a transgenic mice 
implicate DYRK1A in Down syndrome motor dysfunction. Neurobiology of 
Disease, 15(1), 132-142.  
McTighe, S. M., Mar, A. C., Romberg, C., Bussey, T. J., & Saksida, L. M. (2009). A new 
touchscreen test of pattern separation: effect of hippocampal lesions. Neuroreport, 
20(9), 881-885.  
Mereles, D., & Hunstein, W. (2011). Epigallocatechin-3-gallate (EGCG) for clinical 
trials: more pitfalls than promises? International journal of molecular sciences, 
12(9), 5592-5603.  
Miranda, S. B., & Fantz, R. L. (1974). Recognition memory in Down's syndrome and 
normal infants. Child development, 651-660.  
Møller, R. S., Kübart, S., & Hoeltzenbein, M. (2008). Truncation of the Down syndrome 
candidate gene DYRK1A in two unrelated patients with microcephaly. The 
American Journal of ….  
Morris, R. G. (2003). Long-term potentiation and memory. Philos Trans R Soc Lond B 
Biol Sci, 358(1432), 643-647. doi:10.1098/rstb.2002.1230 
Motte, J., & Williams, R. S. (1989). Age-related changes in the density and morphology 
of plaques and neurofibrillary tangles in Down syndrome brain. Acta 
Neuropathologica, 77(5), 535-546. doi:10.1007/BF00687256 
Mu, Y., Lee, S. W., & Gage, F. H. (2010). Signaling in adult neurogenesis. Current 
opinion in neurobiology, 20(4), 416-423.  
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992). NeuN, a neuronal specific nuclear 
protein in vertebrates. Development, 116(1), 201-211.  
Najas, S., Arranz, J., Lochhead, P. A., Ashford, A. L., Oxley, D., Delabar, J. M., . . . 
Arbonés, M. L. (2015). DYRK1A-mediated Cyclin D1 Degradation in Neural 
Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome. 
EBioMedicine, 2(2), 120-134.  
Nakashiba, T., Cushman, J. D., Pelkey, K. A., Renaudineau, S., Buhl, D. L., McHugh, T. 
J., . . . McBain, C. J. (2012). Young dentate granule cells mediate pattern 
separation, whereas old granule cells facilitate pattern completion. Cell, 149(1), 
188-201.  
Nakashiba, T., Young, J. Z., McHugh, T. J., Buhl, D. L., & Tonegawa, S. (2008). 
Transgenic inhibition of synaptic transmission reveals role of CA3 output in 
hippocampal learning. Science, 319(5867), 1260-1264.  
Netzer, W. J., Powell, C., Nong, Y., Blundell, J., Wong, L., Duff, K., . . . Greengard, P. 
(2010). Lowering beta-amyloid levels rescues learning and memory in a Down 
syndrome mouse model. PLoS One, 5(6), e10943-e10943. 
doi:10.1371/journal.pone.0010943 
Neunuebel, J. P., & Knierim, J. J. (2014). CA3 retrieves coherent representations from 
degraded input: direct evidence for CA3 pattern completion and dentate gyrus 
pattern separation. Neuron, 81(2), 416-427.  
 
 
61 
 
 
6
1
 
Nowakowski, R. S., Lewin, S. B., & Miller, M. W. (1989). Bromodeoxyuridine 
immunohistochemical determination of the lengths of the cell cycle and the DNA-
synthetic phase for an anatomically defined population. J Neurocytol, 18(3), 311-
318.   
Numminen, H., Service, E., Ahonen, T., & Ruoppila, I. (2001). Working memory and 
everyday cognition in adults with Down's syndrome. J Intellect Disabil Res, 45(Pt 
2), 157-168.  
Nygaard, E., Ludvig Reichelt, K., & Fagan, J. (2001). The relation between the 
psychological functioning of children with Down syndrome and their urine 
peptide levels and levels of serum antibodies to food proteins. Down Syndrome 
Research and Practice, 6(3), 139-145.  
O'Doherty, A., Ruf, S., Mulligan, C., Hildreth, V., Errington, M. L., Cooke, S., . . . 
Fisher, E. M. (2005). An aneuploid mouse strain carrying human chromosome 21 
with Down syndrome phenotypes. Science, 309(5743), 2033-2037. 
doi:10.1126/science.1114535 
Ortiz-Abalia, J., Sahún, I., Altafaj, X., Andreu, N., Estivill, X., Dierssen, M., & Fillat, C. 
(2008). Targeting Dyrk1A with AAVshRNA attenuates motor alterations in 
TgDyrk1A, a mouse model of Down syndrome. Am J Hum Genet, 83(4), 479-
488. doi:10.1016/j.ajhg.2008.09.010 
Parker, S. E., Mai, C. T., Canfield, M. A., Rickard, R., Wang, Y., Meyer, R. E., . . . 
Kirby, R. S. (2010). Updated national birth prevalence estimates for selected birth 
defects in the United States, 2004–2006. Birth Defects Research Part A: Clinical 
and Molecular Teratology, 88(12), 1008-1016.  
Peißner, W., Kocher, M., Treuer, H., & Gillardon, F. (1999). Ionizing radiation-induced 
apoptosis of proliferating stem cells in the dentate gyrus of the adult rat 
hippocampus. Molecular brain research, 71(1), 61-68.  
Pennington, B. F., Moon, J., Edgin, J., Stedron, J., & Nadel, L. (2003). The 
neuropsychology of Down syndrome: evidence for hippocampal dysfunction. 
Child development, 74(1), 75-93.   
Piatti, V. C., Ewell, L. A., & Leutgeb, J. K. (2013). Neurogenesis in the dentate gyrus: 
carrying the message or dictating the tone. Frontiers in neuroscience, 7.  
Pinter, J. D., Brown, W. E., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. 
(2001a). Amygdala and hippocampal volumes in children with Down syndrome: a 
high-resolution MRI study. Neurology, 56(7), 972-974.   
Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001b). 
Neuroanatomy of Down's syndrome: a high-resolution MRI study. The American 
journal of psychiatry, 158(10), 1659-1665.   
Pletcher, M. T., Wiltshire, T., Cabin, D. E., Villanueva, M., & Reeves, R. H. (2001). Use 
of comparative physical and sequence mapping to annotate mouse chromosome 
16 and human chromosome 21. Genomics, 74(1), 45-54.  
Pons-Espinal, M., Martinez de Lagran, M., & Dierssen, M. (2013). Environmental 
enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in 
TgDyrk1A. Neurobiology of Disease, 60, 18-31.  
 
62 
 
 
6
2
 
Popov, V. I., Kleschevnikov, A. M., Klimenko, O. A., Stewart, M. G., & Belichenko, P. 
V. (2011). Three‐dimensional synaptic ultrastructure in the dentate gyrus and 
hippocampal area CA3 in the Ts65Dn mouse model of down syndrome. Journal 
of Comparative Neurology, 519(7), 1338-1354.  
Prasher, V. P. (1993). Seizures associated with fluoxetine therapy. Seizure, 2(4), 315-317.   
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., . . . 
Davisson, M. T. (1995a). A mouse model for Down syndrome exhibits learning 
and behaviour. Nature genetics, 11.  
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., . . . 
Davisson, M. T. (1995b). A mouse model for Down syndrome exhibits learning 
and behaviour deficits. Nat Genet, 11(2), 177-184. doi:10.1038/ng1095-177 
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., . . . 
Davisson, M. T. (1995c). A mouse model for Down syndrome exhibits learning 
and behaviour deficits. Nature genetics, 11(2), 177-184. doi:10.1038/ng1095-177 
Reinholdt, L. G., Ding, Y., Gilbert, G. T., Czechanski, A., Solzak, J. P., Roper, R. J., . . . 
Davisson, M. T. (2011). Molecular characterization of the translocation 
breakpoints in the Down syndrome mouse model Ts65Dn. Mammalian Genome, 
22(11-12), 685-691.  
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003). 
Memantine in moderate-to-severe Alzheimer's disease. New England Journal of 
Medicine, 348(14), 1333-1341.  
Rezai-Zadeh, K., Shytle, D., & Sun, N. (2005). Green tea epigallocatechin-3-gallate 
(EGCG) modulates amyloid precursor protein cleavage and reduces cerebral 
amyloidosis in Alzheimer transgenic mice. The Journal of ….   
Ribak, C. E., & Seress, L. (1983). Five types of basket cell in the hippocampal dentate 
gyrus: a combined Golgi and electron microscopic study. Journal of 
neurocytology, 12(4), 577-597.  
Rogers, D. C., Jones, D. N., Nelson, P. R., Jones, C. M., Quilter, C. A., Robinson, T. L., 
& Hagan, J. J. (1999). Use of SHIRPA and discriminant analysis to characterise 
marked differences in the behavioural phenotype of six inbred mouse strains. 
Behavioural brain research, 105(2), 207-217.  
Roper, R. J., St John, H. K., Philip, J., Lawler, A., & Reeves, R. H. (2006). Perinatal loss 
of Ts65Dn Down syndrome mice. Genetics, 172(1), 437-443. 
doi:10.1534/genetics.105.050898 
Roubertoux, P. L., & Kerdelhué, B. (2006). Trisomy 21: from chromosomes to mental 
retardation. Behavior genetics, 36(3), 346-354. doi:10.1007/s10519-006-9052-0 
Rowitch, D. H., Jacques, B. S.-., Lee, S. M., Flax, J. D., Snyder, E. Y., & McMahon, A. 
P. (1999). Sonic hedgehog regulates proliferation and inhibits differentiation of 
CNS precursor cells. The Journal of neuroscience, 19(20), 8954-8965.  
Rudolph, U., & Möhler, H. (2013). GABAA receptor subtypes: Therapeutic potential in 
Down syndrome, affective disorders, schizophrenia, and autism. Annual review of 
pharmacology and toxicology, 54, 483-507.  
Rueda, N., Florez, J., & Martinez-Cue, C. (2008). Chronic pentylenetetrazole but not 
donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down 
syndrome. Neuroscience letters, 433(1), 22-27.  
63 
 
 
6
3
 
Rueda, N., Flórez, J., & Martínez-Cué, C. (2012). Mouse models of Down syndrome as a 
tool to unravel the causes of mental disabilities. Neural plasticity, 2012.  
Rueda, N., Llorens-Martín, M., Flórez, J., Valdizán, E., Banerjee, P., Trejo, J. L., & 
Martínez-Cué, C. (2010). Memantine normalizes several phenotypic features in 
the Ts65Dn mouse model of Down syndrome. Journal of Alzheimer's disease : 
JAD, 21(1), 277-290. doi:10.3233/JAD-2010-100240 
Sago, H., Carlson, E. J., Smith, D. J., Rubin, E. M., Crnic, L. S., Huang, T. T., & Epstein, 
C. J. (2000a). Genetic dissection of region associated with behavioral 
abnormalities in mouse models for Down syndrome. Pediatr Res, 48(5), 606-613. 
doi:10.1203/00006450-200011000-00009 
Sago, H., Carlson, E. J., Smith, D. J., Rubin, E. M., Crnic, L. S., Huang, T. T., & Epstein, 
C. J. (2000b). Genetic dissection of region associated with behavioral 
abnormalities in mouse models for Down syndrome. Pediatric research, 48(5), 
606-613. doi:10.1203/00006450-200011000-00009 
Sahay, A., Scobie, K. N., Hill, A. S., O'Carroll, C. M., Kheirbek, M. A., Burghardt, N. S., 
. . . Hen, R. (2011). Increasing adult hippocampal neurogenesis is sufficient to 
improve pattern separation. Nature, 472(7344), 466-470.  
Salmon, D. P., Zola-Morgan, S., & Squire, L. R. (1987). Retrograde amnesia following 
combined hippocampus-amygdala lesions in monkeys. Psychobiology, 15(1), 37-
47.  
Sato, T., & Miyata, G. (2000). The nutraceutical benefit, part I: green tea. Nutrition, 
16(4), 315-317. doi:10.1016/S0899-9007(99)00301-9 
Saxe, M. D., Battaglia, F., Wang, J.-W., Malleret, G., David, D. J., Monckton, J. E., . . . 
Santarelli, L. (2006). Ablation of hippocampal neurogenesis impairs contextual 
fear conditioning and synaptic plasticity in the dentate gyrus. Proceedings of the 
National Academy of Sciences, 103(46), 17501-17506.  
Schmidt-Sidor, B., Wisniewski, K. E., Shepard, T. H., & Sersen, E. A. (1990). Brain 
growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 
60 months. Clinical neuropathology, 9(4), 181-190.   
Scholzen, T., & Gerdes, J. (2000). The Ki-67 protein: from the known and the unknown. 
Journal of cellular physiology, 182(3), 311-322.  
Scott-McKean, J. J., & Costa, A. C. (2011). Exaggerated NMDA mediated LTD in a 
mouse model of Down syndrome and pharmacological rescuing by memantine. 
Learning & Memory, 18(12), 774-778.  
Segal, M. (1979). A potent inhibitory monosynaptic hypothalamo-hippocampal 
connection. Brain Research, 162(1), 137-141.  
Seki, T. (2002). Expression patterns of immature neuronal markers PSA‐NCAM, CRMP‐
4 and NeuroD in the hippocampus of young adult and aged rodents. J Neurosci 
Res, 70(3), 327-334.  
Shors, T. J., Townsend, D. A., Zhao, M., Kozorovitskiy, Y., & Gould, E. (2002). 
Neurogenesis may relate to some but not all types of hippocampal‐dependent 
learning. Hippocampus, 12(5), 578-584.  
Shott, S. R., Joseph, A., & Heithaus, D. (2001). Hearing loss in children with Down 
syndrome. International journal of pediatric otorhinolaryngology, 61(3), 199-
205.   
64 
 
 
6
4
 
Sidman, R. L., Miale, I. L., & Feder, N. (1959). Cell proliferation and migration in the 
primitive ependymal zone: an autoradiographic study of histogenesis in the 
nervous system. Exp Neurol, 1, 322-333.  
Sloviter, R. S. (1989). Calcium‐binding protein (calbindin‐D28k) and parvalbumin 
immunocytochemistry: localization in the rat hippocampus with specific reference 
to the selective vulnerability of hippocampal neurons to seizure activity. Journal 
of Comparative Neurology, 280(2), 183-196.  
Smith, T. J. (2011). Green tea polyphenols in drug discovery: a success or failure? Expert 
opinion on drug discovery, 6(6), 589-595.  
Song, H.-j., Stevens, C. F., & Gage, F. H. (2002). Neural stem cells from adult 
hippocampus develop essential properties of functional CNS neurons. Nature 
neuroscience, 5(5), 438-445.  
Souchet, B., Guedj, F., Sahún, I., Duchon, A., Daubigney, F., Badel, A., . . . Yu, E. 
(2014). Excitation/inhibition balance and learning are modified by< i> 
Dyrk1a</i> gene dosage. Neurobiology of Disease, 69, 65-75.  
Stark, S. M., Yassa, M. A., Lacy, J. W., & Stark, C. E. (2013). A task to assess behavioral 
pattern separation (BPS) in humans: data from healthy aging and mild cognitive 
impairment. Neuropsychologia, 51(12), 2442-2449.  
Stringer, M., Abeysekera, I., Dria, K. J., Roper, R. J., & Goodlett, C. R. (2015). Low dose 
EGCG treatment beginning in adolescence does not improve cognitive 
impairment in a Down syndrome mouse model. Pharmacol Biochem Behav. 
doi:10.1016/j.pbb.2015.09.002 
Takashima, S., Becker, L. E., Armstrong, D. L., & Chan, F. (1981). Abnormal neuronal 
development in the visual cortex of the human fetus and infant with down's 
syndrome. A quantitative and qualitative golgi study. Brain Research, 225(1), 1-
21. doi:10.1016/0006-8993(81)90314-0 
Takashima, S., Iida, K., Mito, T., & Arima, M. (1994). Dendritic and histochemical 
development and ageing in patients with Down's syndrome. Journal of 
intellectual disability research : JIDR, 38 ( Pt 3), 265-273.  
Talpos, J., McTighe, S., Dias, R., Saksida, L., & Bussey, T. (2010). Trial-unique, delayed 
nonmatching-to-location (TUNL): a novel, highly hippocampus-dependent 
automated touchscreen test of location memory and pattern separation. 
Neurobiology of learning and memory, 94(3), 341-352.  
Tashiro, A., Makino, H., & Gage, F. H. (2007). Experience-specific functional 
modification of the dentate gyrus through adult neurogenesis: a critical period 
during an immature stage. The Journal of neuroscience, 27(12), 3252-3259.  
Taupin, P. (2007). Potential of adult neural stem cells for cellular therapy. Biologics: 
targets & therapy, 1(1), 53.  
Teipel, S. J., Schapiro, M. B., Alexander, G. E., Krasuski, J. S., Horwitz, B., Hoehne, C., 
. . . Hampel, H. (2003). Relation of corpus callosum and hippocampal size to age 
in nondemented adults with Down's syndrome. The American journal of 
psychiatry, 160(10), 1870-1878.   
Tejedor, F. J., & Hämmerle, B. (2011). MNB/DYRK1A as a multiple regulator of 
neuronal development. FEBS journal, 278(2), 223-235.  
65 
 
 
6
5
 
Tronel, S., Belnoue, L., Grosjean, N., Revest, J. M., Piazza, P. V., Koehl, M., & Abrous, 
D. N. (2012). Adult‐born neurons are necessary for extended contextual 
discrimination. Hippocampus, 22(2), 292-298.  
Tubman, T. R., Shields, M. D., Craig, B. G., Mulholland, H. C., & Nevin, N. C. (1991). 
Congenital heart disease in Down's syndrome: two year prospective early 
screening study. BMJ (Clinical research ed.), 302(6790), 1425-1427.   
und Halbach, O. v. B. (2007). Immunohistological markers for staging neurogenesis in 
adult hippocampus. Cell and tissue research, 329(3), 409-420.  
Urbach, A., Robakiewicz, I., Baum, E., Kaczmarek, L., Witte, O. W., & Filipkowski, R. 
K. (2013). Cyclin D2 knockout mice with depleted adult neurogenesis learn 
Barnes maze task. Behavioral neuroscience, 127(1), 1-1.  
Van Praag, H., Kempermann, G., & Gage, F. H. (1999). Running increases cell 
proliferation and neurogenesis in the adult mouse dentate gyrus. Nature 
neuroscience, 2(3), 266-270.  
Velazquez, R., Ash, J. A., Powers, B. E., Kelley, C. M., Strawderman, M., Luscher, Z. I., 
. . . Strupp, B. J. (2013). Maternal choline supplementation improves spatial 
learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of 
Down syndrome. Neurobiology of Disease, 58, 92-101. 
doi:10.1016/j.nbd.2013.04.016 
Vicari, S., Bellucci, S., & Carlesimo, G. A. (2005). Visual and spatial long-term memory: 
differential pattern of impairments in Williams and Down syndromes. 
Developmental Medicine & Child Neurology, 47(5), 305-311. 
doi:10.1017/S0012162205000599 
Vicari, S., Carlesimo, A., & Caltagirone, C. (1995). Short-term memory in persons with 
intellectual disabilities and Down's syndrome. J Intellect Disabil Res, 39 ( Pt 6), 
532-537.  
Vivar, C., Potter, M. C., Choi, J., Lee, J.-y., Stringer, T. P., Callaway, E. M., . . . van 
Praag, H. (2012). Monosynaptic inputs to new neurons in the dentate gyrus. Nat 
Commun, 3, 1107.  
Vivar, C., & Van Praag, H. (2013). Functional circuits of new neurons in the dentate 
gyrus. Frontiers in neural circuits, 7.  
Vukšić, M., Petanjek, Z., Rašin, M. R., & Kostović, I. (2002). Perinatal growth of 
prefrontal layer III pyramids in down syndrome. Pediatric Neurology, 27(1), 36-
38. doi:10.1016/S0887-8994(02)00380-6 
Wang, Y., Li, M., Xu, X., Song, M., Tao, H., & Bai, Y. (2012). Green tea 
epigallocatechin-3-gallate (EGCG) promotes neural progenitor cell proliferation 
and sonic hedgehog pathway activation during adult hippocampal neurogenesis. 
Mol Nutr Food Res, 56(8), 1292-1303. doi:10.1002/mnfr.201200035 
Warner‐Schmidt, J. L., & Duman, R. S. (2006). Hippocampal neurogenesis: opposing 
effects of stress and antidepressant treatment. Hippocampus, 16(3), 239-249.  
Weis, S., Weber, G., Neuhold, A., & Rett, A. (1991). Down syndrome: MR 
quantification of brain structures and comparison with normal control subjects. 
AJNR. American journal of neuroradiology, 12(6), 1207-1211.   
66 
 
 
6
6
 
Weiss, C., Bouwmeester, H., Power, J. M., & Disterhoft, J. F. (1999). Hippocampal 
lesions prevent trace eyeblink conditioning in the freely moving rat. Behavioural 
brain research, 99(2), 123-132.  
Wenzel, H. J., Buckmaster, P. S., Anderson, N. L., Wenzel, M. E., & Schwartzkroin, P. 
A. (1997). Ultrastructural localization of neurotransmitter immunoreactivity in 
mossy cell axons and their synaptic targets in the rat dentate gyrus. Hippocampus, 
7(5), 559-570.  
West, M., Slomianka, L., & Gundersen, H. J. G. (1991). Unbiased stereological 
estimation of the total number of neurons in the subdivisions of the rat 
hippocampus using the optical fractionator. The Anatomical Record, 231(4), 482-
497.  
Wisniewski, K. E. S.-S., B. (1989). Postnatal delay of myelin formation in brains from 
Down syndrome infants and children. Clinical neuropathology, 8(2), 55-62.   
Witter, M. P., & Amaral, D. G. (1991). Entorhinal cortex of the monkey: V. Projections 
to the dentate gyrus, hippocampus, and subicular complex. Journal of 
Comparative Neurology, 307(3), 437-459.  
Xie, W., Ramakrishna, N., Wieraszko, A., & Hwang, Y.-W. (2008). Promotion of 
neuronal plasticity by (−)-epigallocatechin-3-gallate. Neurochemical research, 
33(5), 776-783.  
Yabut, O., Domogauer, J., & D'Arcangelo, G. (2010). Dyrk1A overexpression inhibits 
proliferation and induces premature neuronal differentiation of neural progenitor 
cells. The Journal of neuroscience, 30(11), 4004-4014.  
Yamakawa, K. (2012). Towards the understanding of Down syndrome using mouse 
models. Congenit Anom (Kyoto), 52(2), 67-71.  
Yassa, M. A., Lacy, J. W., Stark, S. M., Albert, M. S., Gallagher, M., & Stark, C. E. 
(2011). Pattern separation deficits associated with increased hippocampal CA3 
and dentate gyrus activity in nondemented older adults. Hippocampus, 21(9), 968-
979.  
Yassa, M. A., & Stark, C. E. L. (2011). Pattern separation in the hippocampus. Trends in 
neurosciences, 34(10), 515-525.  
Yoo, K. Y., Choi, J. H., Hwang, I. K., Lee, C. H., Lee, S. O., Han, S. M., . . . Won, M. H. 
(2010). (-)-Epigallocatechin-3-gallate increases cell proliferation and neuroblasts 
in the subgranular zone of the dentate gyrus in adult mice. Phytother Res, 24(7), 
1065-1070. doi:10.1002/ptr.3083 
Yoon, P. W., Freeman, S. B., Sherman, S. L., Taft, L. F., Gu, Y., Pettay, D., . . . Hassold, 
T. J. (1996). Advanced maternal age and the risk of Down syndrome 
characterized by the meiotic stage of chromosomal error: a population-based 
study. Am J Hum Genet, 58(3), 628.  
Zhang, J., Ji, F., Liu, Y., Lei, X., Li, H., Ji, G., . . . Jiao, J. (2014). Ezh2 regulates adult 
hippocampal neurogenesis and memory. The Journal of neuroscience, 34(15), 
5184-5199.  
Zhao, C., Deng, W., & Gage, F. H. (2008). Mechanisms and functional implications of 
adult neurogenesis. Cell, 132(4), 645-660.  
67 
 
 
6
7
 
Zhao, C., Teng, E. M., Summers, R. G., Ming, G.-l., & Gage, F. H. (2006). Distinct 
morphological stages of dentate granule neuron maturation in the adult mouse 
hippocampus. The Journal of neuroscience, 26(1), 3-11.  
Zigman, W. B., & Lott, I. T. (2007). Alzheimer's disease in Down syndrome: 
neurobiology and risk. Mental retardation and developmental disabilities 
research reviews, 13(3), 237-246.  
  
5
8
 
 
 
 
 
 
 
 
 
TABLES 
 
 
 
 
 
 
 
68 
 
 
6
8
 
TABLES 
Table 3.1 Ts65Dn control separation performance 
The euploid (Eu) animals performed significantly different in separation 1 versus 
separation 2 (p=0.001) and separation 1 versus separation 3 (p=0.001).  However, they 
were not significantly different in separation 2 versus separation 3 performance 
(p=0.524).  The trisomic (Ts) animals performed significantly worse in separation 1 
versus separation 2.  However, there were no performance differences in separation 1 
versus separation 3, as well as separation 2 versus separation 3. 
 
 
 
 
 
Eu+ Water 
N=18 
Pair 1 S1 vs S2 61.67% vs 69.57% p=0.001 
Pair 2 S1 vs S3 61.67% vs 70.88% p=0.001 
Pair 3 S2 vs S3 69.57% vs 70.88% p=0.524 
 
Ts+Water 
N=11 
Pair 1 S1 vs S2 53.67% vs 64.10% p=0.006 
Pair 2 S1 vs S3 53.68% vs 60.65% p=0.090 
Pair 3 S2 vs S3 64.09% vs 60.65% p=0.209 
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Table 3.2 Effect of EGCG on cellular proliferation in the dentate gyrus of Ts65Dn 
mice 
There were no significant differences between euploid (Eu) and Ts65Dn (Ts) mice in 
measures of total slices counted, average thickness of the slices counted, total volume, 
average volume per slice, density or coefficient of error.  There was a significant 
difference in total cell counts, with Eu mice have higher cell counts than the Ts mice. 
  
Slice Count Thickness 
Total Volume 
(mm3) 
Average Volume 
Per Slice 
Total Cell 
Counts 
Density 
(counts/volume) 
Coefficient 
of Error 
Eu+Water
, n=6 
14.3333 23.2120 0.1023 x 10-9 7143007.8910 358.8333 3.6315 x10-6 0.0100 
0.9545 0.6569 0.0129 x 10-9 730622.6161 38.4737 0.3499 x10-6  0.3499 
Eu+EGC
G, n=6 
15.5000 23.8779 0.0885 x 10-9 5522177.3210 287.8333 3.6255 x10-6 0.0100 
1.1762 1.5964 0.0151 x 10-9 558953.0661 24.5987 0.5794 x10-6 0.5794 
Ts+Water, 
n=6 
12.5000 22.4610 0.0713 x 10-9 5644649.1870 210.3333 3.1625 x10-6 0.0107 
1.2042 0.3382 0.0099 x 10-9 526703.6947 30.4014 0.4915 x10-6 0.4915 
Ts+EGCG
, n=4 
14.2500 23.0131 0.0819 x 10-9 5731911.8270 251.7500 3.1770 x10-6 0.0101 
0.8539 1.0839 0.0093 x 10-9 449269.4504 13.7257 0.3604 x10-6 0.3604 
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Figure 2.1 Pattern separation maze apparatus 
The pattern separation apparatus was an eight arm radial maze.  Visual cues were placed 
around the maze, and included posters, shelves and a curtain. 
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Figure 2.2 Study timeline 
Treatment began on PD22 and continued throughout the duration of testing.  On PD60, 
mice received daily injections of either saline or BrdU for four consecutive days.  
Animals were then food restricted and handled for seven days, followed by four days of 
habituation to the maze.  The animals were then tested for eighteen consecutive days on 
the pattern separation task.  After testing was completed, mice were either sacrificed (cell 
survival study) or given ad lib food for approximately five days (cell proliferation study).  
Then, the proliferation animals were sacrificed on PD97. 
 
EGCG (50mg/kg/day; 0.4mg/mL) or Water 
Treatment 
Food restrict (85%) & handle 
4 daily BrdU (cell survival)  
or saline (proliferation) 
injections 
Habituation to pattern separation maze 
 BrdU injection & Sac (Proliferation) 
Pattern Separation Testing (6 trials per day) 
Kill (Survival) Food ad lib (Proliferation) 
PD22-PD97 
 
PD9
7 
PD75-PD92 
PD92-
PD97 
PD71-PD74 
PD64-PD70 
PD60-PD63 
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Figure 2. 3 Start and stop points for immunohistochemistry 
The first row indicates the average starting (left; case #10631) and stopping (right; case 
#10525) points for immunohistochemistry processing.  The second row are images from 
the Allen Mouse Brain Atlas that were used as reference points for the experimenter 
(starting at -1.22mm and ending at -2.18mm). 
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Figure 2.4 Quantification of cells in the dentate gyrus 
The top photo represents BrdU stained cells of the left dentate gyrus at 40x.  The circle 
indicates a BrdU stained cell that is magnified to 1000x in the bottom photo. 
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Figure 3.1 Growth of Ts65Dn mice 
 
 
 
 
 
Figure 3.1 Ts65Dn growth 
The growth of Ts65Dn (Ts) mice was plotted beginning on PD44, and continuing 
throughout testing.  Euploid (Eu) mice weighed significantly more versus the trisomic 
(Ts) mice, but both groups increased their weight as a function of time.  There was a 
main effect of day on growth [F(24,1464)= 272.602, p=<0.001], as well as a main effect 
of genotype (*) [F(1,61)=31.33, p=<0.001]. 
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Figure 3.2 EGCG Consumption in Ts65Dn mice 
There were no differences in the amount of EGCG consumption between the euploid 
(Eu) and trisomic (Ts) mice.  Both groups decreased their EGCG consumption as a 
function of time.  There was a main effect of day on EGCG consumption [F(25,1025)= 
16.629, p=<0.001], but no genotype or interactive effects. 
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Figure 3.3 Ts65Dn acquisition performance on a pattern separation task 
Euploid (Eu) mice displayed a higher overall percentage correct versus the trisomic (Ts) 
mice.  However, both groups improved their performance over time.  There were no 
effects of EGCG on improving performance.  For acquisition, there was a main effect of 
day on performance [F(5,305)= 4.6, p=<0.001], as well as a main effect of genotype (*) 
[F(1,61)= 18.435, p<0.001], but no interactive effects. 
 
 
 
 
 
 
 
 
77 
 
 
7
7
 
Figure 3.4 Ts65Dn separation performance 
Euploid (Eu) mice displayed a higher percentage correct at each degree of separation 
versus the trisomic (Ts) mice.  Both Eu and Ts mice increased their performance as a 
function of separation.  There were no effects of EGCG improving performance.  For 
separation performance, there was a main effect of separation [F(2, 122)= 20.541, 
p<0.001] as well as a main effect of genotype (*) [F(1,61)=21.277, p<0.001], but no 
interactive effects.  
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Figure 3.5 Ts65Dn cell proliferation counts 
The Euploid (Eu) mice had a higher number of cell counts versus the trisomic (Ts) mice.  
There were no effects of EGCG on the number of cell counts.  There was a main effect of 
genotype (*) on the total number of cells counted [F(1,18)=8.83, p=0.008]. 
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